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ABSTRACT
MECHANISMS OF SLOWED FOOT TAP SPEED IN OLDER ADULTS
MAY 2016
ERICA HARTMAN, B.S., UNIVERSITY OF DELAWARE
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Jane A. Kent

Rapid repetitive tapping, like the Foot Tap Test (FTT), slows with age, but the underlying
mechanisms are unknown. Purpose: 1. Test the hypotheses that greater performance
variability, increased muscle coactivation, and slowed muscle contractile speeds are
related to lower foot tap count (FTC) in older adults; 2. Examine the relationship between
FTC and physical function in older adults, using the advanced Short Physical
Performance Battery (SPPB-A), usual and 400m brisk walking speed. Methods: 18
young (25.0±3.1years, 9F, mean±SD), and 28 older (73.4±4.9, 14F) healthy adults were
recruited. The older adults were divided into Higher (HFO) and Lower (LFO)
Functioning based on the median SPPB-A score. Participants performed 10s of rapid
tapping (FTT) while seated with their foot on a force plate. A MATLAB program was
used to calculate FTC and variability of the intertap-interval (COV-ITI). Contractile
speed (rates of force development and relaxation, RFD and RFR) of the dorsiflexor
muscles of the slower leg were determined using voluntary, rapid submaximal (ballistic)
contractions. Electromyography (EMG) was recorded on the tibialis anterior (TA), soleus
(Sol), medial and lateral gastrocnemius during the FTT on the slower foot. Coactivation
was calculated using correlation analyses to determine agreement of TA and Sol
activation during the FTT. Results: The LFO had a lower FTC than Young and HFO
(45.9±7.0taps, 54.4±7.5, 53.1±5.7, respectively; p=0.003), and lower COV-ITI than
iv

Young (12.3±5.9%, 20.5±8.1, respectively, p=0.009). No associations were found in the
older adults between COV-ITI and FTC. The correlation-coefficient of the EMG signals
was higher in Young than HFO (0.568±0.209, 0.321±0.129) and was negatively related
to FTC in older adults (r2=0.274, p=0.005). The LFO had a slower RFD than Young
during ballistic contractions and FTC was positively related to maximal RFD (r2=0.345,
p=0.001) and RFR (r2=0.162, p=0.038) during ballistic contractions in older adults. The
FTC of the faster foot was related to SPPB-A (r2=0.329, p=0.001), but not 400m or usual
walking speed in older adults. Conclusions: Greater muscle coactivation during the FTT
and slower force development in the dorsiflexor muscles may negatively affect FTC in
older adults. In older adults, FTC is related to a composite measure of function.
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CHAPTER 1
INTRODUCTION
During the 7th decade of life, there is usually a decline in physical function
associated with aging. The decrease in physical function is due in part to a number of
changes that occur within the neuromuscular system. In particular, older adults may
have: reduced motor unit (MU) number and increased MU size, decreased muscle mass,
decreased rate of force production and relaxation, decreased ability to fully activate their
muscles, and increased muscle coactivation. Individuals with mobility impairments, such
as those with multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS), have even
greater neuromuscular changes than their healthy counterparts. Several tests have been
validated for identifying individuals with declining physical function, including the 400m
walk and the Short Physical Performance Battery (SPPB) (15, 80). While these tests are
informative and commonly used, the Foot Tap Test (FTT), a 10-second test in which the
participant is asked to tap their foot as quickly as possible, is a novel measure that is
quicker and easier to administer than these other measures of function. The FTT is able
to track changes in central motor control, or the ability to activate and coordinate muscle
contractions, and upper motorneuron dysfunction in aging and diseased populations,
along with having the potential to longitudinally track changes in functional ability (28).
The FTT requires an individual to rapidly activate and deactivate their dorsiflexor
muscles. It has been shown that slowed foot tap speed is a predictor for a decline in gait
speed, particularly in populations with upper motor neuron diseases, such as ALS (27).
Foot tap speed has also been shown to predict a decline in function with age, with older
adults having a slower foot tap speed than younger adults, even when both populations
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have comparable normalized muscle strength and rate of force development in the tibialis
anterior (TA), and ability to activate their TA (29). It is postulated that slower foot tap
speed indicates a decline in central function and that it can be used to identify the decline
in central function earlier than other tests such as the central activation ratio (26, 28).
The cause of the slower foot tap speed in older adults and those with mobility
impairments is still unknown. The slowing of rapid movements in older adults could be
due to a number or neuromuscular changes, such as a slowed rate of force development
and relaxation, a higher prevalence of slow twitch muscle fibers, and a greater amount of
muscle coactivation. While the first two likely contribute to the slowing of movement
with age, they are due to changes in the muscle while greater muscle coactivation is due
to changes in motor control, or the activation and coordination of muscle contractions.
Since FTS has been shown to be slower in individuals with diseases affecting the central
nervous system (CNS), it is possible that coactivation will play a larger role in the
slowing of rapid repetitive movements than peripheral changes due to aging.
Coactivation has been defined in two ways: 1) the quantity of antagonist muscle
activation relative to the quantity of agonist muscle activation:
CoActM (%) =

% 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎
%𝑎𝑎𝑎𝑎𝑎𝑎𝑎 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎

Equation 1

or, 2) the proportion of time that the antagonist is active during agonist activity (CoActT,
% of ms). An increase in coactivation with age is believed to be caused by poor motor
control; for example, coactivations patterns during gait are not the same for affected vs.
unaffected limbs in individuals who have had a stroke (35). Coactivation has been shown
to be highest when performing small, rapid movements (48). However, coactivation is
also an adaptation that could help increase stability around the joints (21). Joint stability
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is important in older adults for a number of reasons, particularly fall prevention. Thus, an
increase in coactivation in the leg muscles could slow the ability to perform rapid
movements but improve joint stability in older adults, resulting in less falls. The Specific
Aims of this study are:
Aim 1: Determine whether coactivation of antagonist muscles is a potential cause of the
slowed foot tap speed in older adults
Hypothesis (H) 1.1. Foot tap speed will be faster in young adults than healthy
older adults, and healthy older adults will have a faster foot tap speed than
mobility-impaired older adults.
H 1.2. CoActM will be longest in mobility impaired older adults, then healthy
older adults, with young adults having the lowest CoActM.
H 1.3. CoActT will be highest in mobility-impaired older adults, then healthy
older adults, with young adults having the shortest amount of CoActT.
H 1.4. CoActM will be indirectly related to foot tap speed in all older adults.
Aim 2: Explore the potential effect of coactivation on physical function in older adults.
H 2.1. CoActM will be higher during gait in older adults than in young, and will
be higher in mobility-impaired adults than healthy older adults.
H 2.2. CoActM will be indirectly associated with gait speed in older adults.
Exploratory analyses of the associations between CoActM and both gait speed
variability during the 400m walk and Fall Efficacy Score-International score will
also be performed.
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Aim 3 (exploratory): To analyze the underlying movement patterns during 10-s FTTs in
young, healthy older and impaired older adults and explore how movement patterns
change during a task where the participant must match a specific speed.
3.1 Evaluate, for each group, dynamic variables such as Intertap-Interval (ITI),
ground reaction force (GRF) and toe excursion for the 10-s FTT. Evaluate how
these dynamic variables change throughout the 90-s FTT in each group.
3.2 Evaluate these variables under conditions of constrained (slow, moderate,
fast) Foot Tap Speed (FTS). Slow will be established as 30% of max FTS from
the 10-s FTT, moderate as 60% of max FTS, and fast as 100% of max FTS.
Significance: This study will further develop and validate the FTT, and will be
the first to determine whether coactivation contributes to the decline in the ability to
perform rapid movements with age. By examining the relationship between FTS and
coactivation, along with other peripheral and central neuromuscular properties, the cause
of slowed FTS in older adults may be identified. To begin to translate these findings to
“real world” conditions, the relationship between coactivation during gait and concerns
about falling will be explored in healthy and impaired older adults.
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CHAPTER 2
LITERATURE REVIEW
Introduction
The number of individuals living past the age of 65 years has increased almost
20% in the past decade, along with an increase in life expectancy (77). A large percent of
these older adults have functional limitations; particularly, 17% of 65-74 year olds and
28% of 75-84 year olds have difficulty walking (77). As individuals age, many
physiological and behavioral changes occur that impact functional ability. Beyond the 7th
decade of life, there are noticeable changes in gait, strength, concerns about falling,
metabolic cost of activity, and physical activity (PA), among others, all of which can
impact an older adult’s functional ability, particularly their mobility (5, 16, 39, 68, 72).
Maintenance of mobility is important for a good quality of life, as it allows for continued
freedom and enables an individual to perform activities of daily living, such as dressing
and grocery shopping, without assistance (65). It is therefore imperative that individuals
with declining function be identified early so appropriate interventions can be
implemented to slow the detrimental effects of aging. For our purpose, aging will be
defined as the changes in cognitive and physical function that occur as we get older.
The SPPB and 400m walk time are commonly used tests which identify
individuals with mobility impairments (15, 80). However, they are more difficult to
perform in small spaces and have not been used to identify individuals with CNS
dysfunction. The FTT is another informative test that is potentially an early predictor of a
decline in function, such as gait speed, and can be used to identify changes within the
CNS (28, 59). The FTT requires rapid activation and deactivation of the dorsiflexor
5

muscles, a task that becomes more difficult with age due to the slowing of rapid
movements, which could be due to changes within the neuromuscular system that occur
with aging. In particular, an increase in coactivation with aging may impact older adults’
ability to rapidly activate and deactivate their muscles, including the muscles around the
ankle joint. Maintenance of function in the dorsiflexor muscles is of particular
importance in older adults due to the role of dorsiflexion in toe clearance during gait (55).
Not only is the FTT an easy and informative marker of changes in the CNS with age, and
it could potentially provide information about muscle recruitment patterns during a task
requiring rapid repetitive activation and how these recruitment patterns are impacted by
age, functional limitations, and movement speed.
This literature review will focus on the FTT, a potential test for predicting a
decline in function with age and disease. It will also address the changes that occur in the
neuromuscular system with aging, particularly the increase in coactivation. The
relationship between coactivation and concerns about falling in older adults will also be
addressed.

Neuromuscular changes with age
With aging, many neuromuscular changes occur that impact an individual’s
functional ability. These changes may include a: 1) decrease in motor unit (MU) number
accompanied by an increase in MU size, 2) decrease in muscle mass, 3) increase in
percentage of slow twitch muscle fibers, 4) decrease in ability to fully activate the
muscle, 5) increase in muscle coactivation, and 6) decrease in rate of force production
and relaxation. These neuromuscular changes are linked to a slowing in movement speed
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(28, 72), a higher metabolic cost of activity (20), and lower power and strength (12) in
older adults, all of which could impact older adults’ ability to function independently. It
is important to note that the decline in PA that usually occurs with age may also play a
role in many of these changes; this problem will be discussed later.
The neuromuscular changes that occur with aging are due to changes both within
the nervous system and the muscle itself. One of the main causes of the neuromuscular
changes with aging is motor neuron death, which impacts the arrangement of MUs in the
muscle (43). A MU is composed of a motor neuron and the muscle fibers it innervates.
After the death of a motor neuron, some of its muscle fibers are reinnervated by another
motor neuron, resulting in increased size of the remaining MU (43, 44). A larger MU
means that an individual motor neuron is responsible for the innervation of more muscle
fibers. Older adults recruit larger MUs when performing tasks, which could impact their
ability to modulate their movements, resulting in increased difficulty of fine motor tasks
(44).
There is also a loss in the number of muscle fibers with aging, suggesting that
complete reinnervation by motor neurons does not occur (42). Both Type I and Type II
muscle fibers are affected by motor neuron death, with a greater prevalence of loss of
Type II fibers, thereby increasing the percentage of slow twitch fibers in older adults (39,
41). The reduction in the size and number of muscle fibers results in a loss of muscle
mass, or sarcopenia, and a loss in strength, but not necessarily a loss in specific strength,
which is strength relative to muscle mass (29).
Changes in the CNS with age can result in poor regulation and incomplete muscle
activation. An impairment of voluntary muscle activation means that an individual is not
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able to fully activate all MUs and potentially has a reduction in maximal discharge rate of
the motorneuron when performing a maximal voluntary contraction (MVC; (26). The
central activation ratio (CAR), or ratio of force produced during an isometric contraction
relative to a stimulated contraction (isometric MVC/(MVC+superimposed tetanic
stimulation)), is a measure that can indicate if there is an impairment in an individual’s
ability to fully activate the muscle (CAR<1; (26, 29). A lower CAR score is seen in
individuals who have an impairment of the CNS, and thus, decreased motor control (26),
but is rarely seen in healthy older adults (29, 79). A decline in motor control can also
results in greater coactivation during movement (20, 21, 33, 53, 66), which will be
discussed in detail later. Motor unit discharge rate has been shown to decrease with age;
for instance, older adults have been shown to have a lower MU discharge rate than
younger adults during maximal and submaximal (50% of MVC) isometric contractions,
with a greater difference at higher forces (24, 61).
The maximal rate of force development and half relaxation time (T1/2) are usually
slower in older muscles than younger ones (6, 31, 49). A reduced rate of force
development during a submaximal voluntary contraction relative to a stimulated
contraction can be indicative of changes in upper motor neuron function, and has been
shown to be correlated with slower foot tapping (26). Both of these muscle properties
can be determined by stimulating the nerve of interest, which removes the voluntary
component of the contraction (26). Together, the rate of force development and T1/2
contribute to contraction duration (time to peak tension + ½ relaxation time), which tends
to be longer in older adults for the tibialis anterior (TA) and plantar flexor muscles, which
could impact older adults’ ability to perform rapid contractions (57, 79). However, aging
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has less of an impact on contraction duration in the thigh muscles, highlighting the fact
that muscles are impacted by aging differently (31, 78).
Muscle groups do not change equally with age, partially because some muscles
are essential for performing activities of daily living, such as walking, while others are
used less frequently. For the purpose of this paper, the focus will be on the ankle
dorsiflexor muscles, specifically the TA. It has been shown that there are significantly
fewer MU in the TA in old (mean age 66 yrs) and very old (mean age 82 yrs) men than in
young (mean age 27) men. Additionally, older men had fewer MUs than very old men,
indicating an aging effect on MU number in the TA (49).
Studies have shown that there is a decrease in muscle mass with age in the
dorsiflexors (29, 79), along with a decrease in strength (6, 49, 79), though not necessarily
specific strength (29, 79). Age also does not have an impact on voluntary activation of
the dorsiflexors, meaning older adults can fully activate their TA and they do not have a
reduced CAR (6, 29, 32). In the TA, it is unclear whether the rate of force development
changes with age, with some studies finding a significant difference (6, 32, 49) and others
not (29), though this difference could be due to varying definitions for rate of force
development. Contraction and relaxation durations in the TA have also been reported to
last longer in older adults (6, 32, 49).
Some studies have reported a higher amount of muscle coactivation in the
antagonist muscles during dorsiflexion in older adults during gait (10, 22, 53, 66) and
postural control tasks (53), while others have found no difference in lower leg
coactivation during gait with age (32, 64) and during isometric, concentric and eccentric
contractions (32). Changes in the TA with age can impact toe clearance in gait, which is
9

a significant risk factor for falls in the elderly (55). It is therefore important to identify
changes in the TA’s function, such as the ability to rapidly activate and deactivate it,
which could be important for catching onself after a lose of balance.

Foot Tap Speed
The ability to perform rapid movements, such as finger and foot tapping,
decreases with changes in the neuromuscular system that are associated with aging and
disease (51, 59). Rapid finger tapping is used by neurologists to track the progression of
diseases impacting the upper motor neurons (UMN) by comparing finger tapping speed
longitudinally, and against a normal population (51). A rapid FTT is indicative of
changes in motor control that occur in diseases that affect the CNS (14, 27, 51, 58, 59),
and with aging (29, 59). Foot tapping likely requires the rapid recruitment and
derecruitment of MU (9), and the modulation of the number of MU recruited because it is
a fine, submaximal, movement. For the FTT, participants are asked to tap their foot as
rapidly as possible for 10s, a task which is more difficult for individuals with mobility
and motor impairments.
The results of recent studies suggest that the FTT is potentially an informative
measure of changes within the central motor system. Foot Tap Speed is lower in
individuals who have diseases that affect the central motor system such as cervical
myelopathy (59), multiple sclerosis (58), Parkinsons’(14), and amyotrophic lateral
sclerosis (ALS) (27, 50, 51). The FTT is a measure that can be implemented in the
clinical setting since it requires only a chair and a tap counter, and has already been
shown to be correlated with results from current clinical tests (27, 50). In a study by
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Miller et al., physicians were asked to identify the affected leg of individuals who had
mild weakness in their leg brought on by an UMN disease using the Babinski sign, a
commonly used neurological test for identifying an abnormality in the plantar reflex
which is indicative of CNS dysfunction, and the FTT (50). This study found that the
physicians were able to identify the affected limb with more accuracy and confidence
using the FTT than the Babinski sign (50). In a study of neuromuscular differences in
individuals with ALS, Kent-Braun et al., found that individuals with an impaired UMN
function due to ALS, had a reduced ability to perform fine, rapid movements, measured
using maximal rate of voluntary force rise and FTS (27). Foot Tap Speed was correlated
with the Ashworth spasticity score (P=0.02) in the ALS participants, and a 6-month
follow up showed a significant reduction in FTS in this population (27). The FTT is
already in use by neurologists for assessment of the above mentioned diseases, but its
clinical use in aging populations is still being developed.
Foot Tap Speed also decreases with age, is strongly correlated with functional
measures and other predictors of mobility impairment, such as gait speed, and can
identify individuals at risk for future mobility impairments (28, 59). Numasawa et al.
examined FTS in 792 healthy adults ranging in age from 20-83 years old and found that
FTS and age were moderately negatively correlated (R= -0.369, P<0.0001; (59). This
study also found that FTS was strongly correlated with lower extremity motor function,
as quantified by the modified Japanese Orthopedic Association (59). Submitted data
from Kent-Braun et al. examined FTS and walking speed in 9,698 women over the age of
65 years old, and found that a slower FTS was directly associated with a lower gait speed
and effectively predicts slower gait speed at a 2 year follow up (28). Additionally, this
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study found a correlation between faster FTS and higher physical function, quantified as
greater PA, greater grip strength, faster completion of 5-chair rises, and balancing longer
in a tandem stand (28). While the use of FTT to track changes in aging is relatively new,
the results of the above studies highlight the potential possibilities of the FTT.
The cause of the decrease in FTS with age is unknown. In a study by Kent-Braun
et al. the properties of the TA were studied extensively in young (25-44 years) and older
(65-83 years) men and women with comparable PA levels (29). The groups were
compared on specific strength, normalized maximal rate of force development (RFD),
CAR, and FTS. Normalized maximal RFD, CAR and FTS are all measures that are
believed to indicate central deficit but only FTS was statistically different between the
young (47 ±1 tap/10s) and older (34±1 tap/10s) group (29). This study found that the
older group had an impaired ability to perform these rapid dynamic contractions, but did
not have a difference in other properties in the TA (29). Additionally, it suggests that the
FTS may be a more sensitive indicator of changes within the CNS than normalized
maximal RFD and CAR, potentially causing FTS to be an early detection mechanism for
changes in the CNS. The above-mentioned study called into question why FTS decreases
with age, and highlighted the need for additional studies to determine which changes in
the neuromuscular system with age are the source of this slowing.

Control of rapid movements
The ability to rapidly tap one’s foot can be impacted by central or peripheral
changes in the neuromuscular system. Centrally, MU discharge (i.e., firing) rate and
rapid modulation of MUs control how quickly the motor neurons can be activated and
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deactivated (9). In young adults, MU firing rate is higher and force required to active a
MU is lower during rapid isometric contractions than when performing ramp isometric
protocols, with the firing rate of the TA reaching 60-120 Hz during ballistic contractions
(9). In a study by Klass et al., the firing rate of MUs in the TA during rapid isometric
contractions was found to be higher in young adults than older adults (31). The change in
firing rate between the MU’s first, second and third discharge was also examined in
young and older adults, and older adults were found to have a greater decrease in firing
rate during the successive firings when compared with young adults (31). Additionally, it
has been found that older adults have a lower MU force threshold in the TA than younger
adults while performing isometric contractions (6). These studies suggest that MU firing
rate is higher and the force threshold is lower during rapid contractions, and that young
adults have higher MU firing rates and a higher force threshold than older adults (6, 9,
31). While these studies were isometric and the rapid contractions were not isolated vs
successive, they provide insight into how MU recruitment might change during rapid,
repetitive contractions in young and older adults.
Peripherally, the rate of activation and deactivation of the TA is controlled by
RFD and relaxation time. In a study by Klass et al., older adults had lower maximal RFD
and had longer time to peak torque during fast contractions of the TA when compared
with young adults (31). Kent-Braun et al. did not find a difference in rate of force
development during rapid isometric contractions with aging; however this is likely due a
difference in methodology (29). This study expressed voluntary rate of force
development relative to maximal stimulated rate of torque development in order to
account for peripheral changes in the muscles, thus using rate of force development as a
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central, not peripheral, measure (29). If the muscle has a reduced rate of force relaxation,
it will take longer before the muscle can be activated again.
In addition to the changes in central and peripheral factors discussed above,
changes in motor control, such as regulation of antagonist activity (48), could impact the
ability to perform rapid movements in older adult.

Coactivation
Some studies have shown that older adults use greater coactivation than younger
adults while performing a range of activities. Coactivation is defined here in two ways:
1) the quantity of antagonist activation relative to the quantity of agonist activation, or
CoActM (Equation 1); and 2) the amount of time in which the antagonist is active during
the agonist activity, (CoActT, ms). Antagonist activity is not consistent across all muscle
groups and actions. Coactivation tends to be higher in individuals with decreased
postural stability, decreased motor control, and/or greater mobility impairment.
Older adults tend to use greater coactivation in their legs than young adults.
Thigh CoActM has been shown to be higher in older adults while they are walking (64,
66), and climbing up and down stairs (21, 38). There are inconsistencies in the literature
with regard to shank coactivation, with some studies finding that CoActM does not differ
between old and young while walking (10, 64), or when performing isometric, concentric
or eccentric contractions (32), while others report a difference in CoActM during gait (22,
53, 66) and static standing (40, 53). CoActT of the TA and plantar flexors was found to
be different between young and older adults in studies of gait and stair climbing (10, 22),
with older adults having a greater overlap in timing of the activation of the TA and
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gastrocnemius muscles, due to earlier onset and later offset of the gastrocnemius muscles
(22). Coactivation could be impacted by gait changes that occur with aging, such as a
change in muscle recruitment patterns and power during gait (45, 60, 66, 82). Older
adults tend to walk slower, take shorter steps, have lower push-off power, and spend
more time in double limb support (30, 45, 60, 82), with an even greater reduction of these
parameters seen in older adults with reduced knee and ankle strength (36). Older adults
also tend to have a decreased hip and ankle range of motion which could be related to a
decline in maximal knee strength with age (34).
Coactivation during rapid movements is an area of research that has not been
explored extensively. In a study on coactivation during elbow extension, Mardsen et al.
found that coactivation was highest while performing small movements at high velocities
in the elbow extensors (48). Conversely, Klass et al. found that CoActM was not different
when performing rapid movements, finding no difference in the amount of antagonist
soleus activity relative to the TA’s activity when performing fast, isometric dorsiflexion
contractions in young and older adults (31). Coactivation has also been shown to
increase with gait speed in both young and older adults, but this could be due to the
difference in the tasks being performed (22). Additionally, a negative correlation has
been shown between RFD and coactivation in the knee extensors and flexors in older
adults, suggesting that greater coactivation could reduce the speed of force development
(62). It is evident that additional research is needed to understand how coactivation may
impact rapid movements in young and older adults.
It is unclear whether an increase in coactivation with age is a beneficial or
harmful adaption, but more than likely it is both. Higher coactivation occurs because
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more antagonist muscle fibers are recruited, which can decrease force output and increase
the metabolic cost of movement. Higher antagonist activity might be an adaptation used
to increase stiffness around the joint and thus an older adults’ stability, or it could be due
to poor motor control. A full understanding of the consequences of increased coactivation
with aging remains to be determined.
With greater antagonist activity, it is likely that more MU are recruited in both the
agonist and antagonist muscles. Greater antagonist activity could cause a reduction in
force capability in older adults (46). To counter-act this increase in antagonist activity, it
is possible that more MU in the agonist would be required. The increase in agonist and
antagonist muscle activity likely leads to a higher metabolic cost of movement, which has
been linked to the slowing of gait speed (67). Previous studies have shown a relationship
between the increased coactivation in leg muscles in older adults and higher metabolic
cost of walking (20, 47, 64).
In contrast to the negative effects of coactivation, increased antagonist activity
helps to stiffen the joint, an adaptation that increases joint stability in older adults.
Hortobagyi et al. found that when performing a downward step, CoActM was 96% higher
in older adults than younger adults, with the vastus lateralis and bicep femoris muscles
having 140% greater activation, and the TA having 120% greater CoActM than young
adults (21). When the relationship between leg stiffness, defined as force production
divided by leg displacement (N·m-1) and muscle activity was examined, the above study
found that 50% of the variance in leg stiffness was accounted for by higher muscle
activity in the older adults (21). The adaptation of increasing leg stiffness by coactivation
has also been seen in studies on individuals who have a fear or history of falling, with
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these individuals having greater muscle coactivation in the lower leg (7, 54). In a study
by Marques et al., which compared gait in fallers and non-fallers, the CoActM ratio for
TA/Lateral Gastrocnemius (GL) was higher in fallers during all phases of gait (47).
However, it is also possible that the higher coactivation seen in fallers is not an
adaptation to increase joint stiffness, but rather because they have worse postural control.
Older adults with who have less physical function during a functional reach task and
greater sway area during static standing have been shown to have great coactivation in
the shank than older adults with better postural control (40, 53).

Falls
Falling is a major concern for older individuals, with about a third of all persons
over 65 experiencing a fall each year (5). Many of these falls lead to minor or major
injuries. There are many different factors that can lead to a loss in stability in older
adults. Fallers, frequently classified as individuals who had fallen, or nearly fallen,
during the past year, tend to have a lower isometric strength in the ankle muscles (37) and
rate of torque development in the dorsiflexor muscles (37, 63), It has been observed that
fallers have a greater asymmetry in isometric dorsiflexor strength than nonfallers, along
with during low velocity eccentric dorsiflexion and plantarflexion (63). Coactivation has
been shown to be greater in fallers during gait (47) while it has not been shown to be
different in the knee or ankle muscles during isometric contraction (37). In addition, a
delay in ankle dorsiflexion at the beginning of the swing phase during gait has been
correlated with higher prevalence of falls (25).
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The Falls Efficacy Scale-International (FES-I) is a 16-question instrument
designed to query individuals about their fear of falling during both basic and more
demanding physical and social activities (83). The FES-I was developed from the Falls
Efficacy Scale (FES). The FES has excellent reliability, is correlated with balance and
gait, and is able to predict future falls and a decline in physical function (75, 83). The
FES-I includes questions that are more relevant to individuals with higher functional
ability, allowing it to discriminate between individuals with a wider range of functional
abilities (83). The FES-I also addresses the impact of an individual’s concern about
falling on their participation in social activity, extending the questionnaire from the FES,
which only focuses on physical situations and consequences. In a one-year follow up
study, the FES-I showed good predictive validity and there was a general increase in
FES-I score with time, indicating a greater concern of falling with age (8).
As discussed previously, coactivation is an adaptation that can help to stabilize
joints. It has been found that older adults who have a fear or history of falling have
greater coactivation than their peers who do not fear falling (40, 47, 54). Marques et al.
found that older females who had fallen in the past year had a higher coactivation ratio
for their TA and GL during gait than older females who had not fallen (47). A study by
Laughton et al. examined postural sway and coactivation during quiet stance, and found
that older adults had a higher rate of coactivation, but there was no difference in
coactivation between fallers and nonfallers, which was possibly due to the already
increased coactivation with age (40). It appears that if an individual is more concerned
about falling, they will try to maintain stability in their joints, which would include
stiffening the joints by increasing the activity of the muscles around the ankle and knee.
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Physical activity and function
The decline in physical function with age greatly impacts the quality of life of
older adults, because it results in greater disability and a decreased ability to perform
activities of daily living (17, 65). A decline in physical function, specifically mobility, is
also accompanied by an increased likelihood of falling, and the fear of falling can impact
the individual’s perceived mobility (2). Lower daily PA has been related to an increase
in mobility impairments and a decrease in functional ability in older adults (52).
Individuals who participate in a greater amount, and a higher intensity, of PA tend to
have a higher gait speed and are less likely to develop sarcopenia (52, 68). Two common
functional tests that have been strongly correlated with declining function in older adults
are the SPPB and gait speed, specifically the 400 m walk.
The SPPB is a common functional test that scores individuals from 0-12 based on
their ability to complete specific tasks (15, 16). The SPPB includes 3 tasks: time to
complete a 4m walk at a casual walking speed, ability to balance for 10s in 3 positions
(tandem, semi-tandem, side-by-side stance), and time to complete 5 chair rises (15, 16).
The SPPB has been correlated with gait speed, and has proven reliable for testing
functional ability in older adults (15). The SPPB has also been shown to predict
morbidity in a 6 year follow up, with morbidity decreasing by 15% for each increase in
SPPB point at baseline (80). An advanced version of the SPPB has also been developed
and allows for the differentiation of individuals who score a 12 on the SPPB, along with
more individualized scores for participants (70). The advanced SPPB (SPPB-A) expands
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on the SPPB, making the tasks slightly longer and more difficult and minimizes the
ceiling effect.
Gait speed has been shown to be a reliable indicator of changes in physical
function and mobility limitations in older adults (16, 72). Preferred gait speed is
correlated with survival rate, with individuals who have a lower gait speed having a
lower survival rate (72). Preferred gait speed during a short walking task, specifically the
4m walk during the SPPB, has been shown to predict future mobility impairments (16).
The 400m walk test is an endurance walk that is performed at a brisk pace. Time for
completion has been related to current functional ability (13) and mobility limitations at a
5 year follow up (56). Time for completion of the 400m walk test is correlated with
survival 6 years later, with individuals who were unable to complete the test or were in
the group which took the longest time to complete the test having the highest rate of
mortality 6 years out (56, 80). A study by Vestergaard et al. also found that a larger
coefficient of variation in lap time, taken across 20 laps, was a predictor of morbidity at
6-year follow up (80). Additionally, greater stride time variability while walking has
been correlated with an increased fall risk in older adults (19).
Foot tap speed has been correlated with gait speed and other functional measures,
indicating that the FTT is a reliable way of predicting mobility impairments (28, 59).
Individuals with mobility limitations have been found to have a lower FTS, gait speed
and SPPB score. However, unlike the 400m walk test and the SPPB, the FTT does not
require an individual to be mobile and could potentially be an early indicator of changes
in the central nervous system (28). However, the FTT is currently limited because it is
susceptible to recorder error. Currently, the FTT is performed by having an individual
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tap their foot rapidly on the floor while someone counts their taps and tells them when to
start and stop (27, 59). However, this method provides a single outcome variable, the
number of taps. It is believed that using a force platform to record the force output of
each tap and motion capture to track the motion of the foot during the task will increase
counting accuracy and provide additional information about how the task is being
performed. Variations on the traditional FTT, such as reducing the rate of tapping, could
provide insight into how individuals approach the task of repetitive contractions and how
speed might impact muscle activation.

Summary
Over the last 100 years, there has been a steady increase in the number of
individuals living past the age of 65, along with an increase in life expectancy (77). A
major concern for these older adults is a decrease in physical function, specifically
mobility, and an increase in the prevalence of falls with aging (5, 65). A simple test, such
as the FTT, could be beneficial for the identification of individuals who are at risk for
mobility impairment due to aging and changes in the CNS. Slowing of FTS has been
shown to be related to a decline in motor control with both disease and aging (28, 51, 58,
59). However, the cause of the decreased ability to rapidly activate and deactive the
dorsiflexors is still unknown. Slowing of muscle properties with age, such as the rate of
muscle activation and relaxation, could impact FTS. However, because FTS has been
shown to be slower in individuals with varying diseases affecting the CNS, it is likely
more strongly impacted by changes in central control (14, 27, 50, 51, 58, 59). Changes in
central control, such as MU recruitment and muscle coactivation, could play a role in the
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slowing of FTS (29, 31, 48, 62). Some studies have found that muscle coactivation in the
lower leg is higher in older adults while walking, preforming postural control tasks, and
standing still (22, 40, 53, 66). While the increase in muscle coactivation with age could
be detrimental due to its correlation with a higher metabolic cost of movement (20, 47,
64), it has also been shown to increase joint stiffness (7, 21, 54). Increased joint stiffness
is believed to be an adaptive mechanism to increase stability in fallers, which is of
particular importance because about one in three older adults fall each year while walking
(5). Further exploration into the cause of slowed FTS with aging could provide new
insight into the relationship between coactivation and the ability to perform rapid
repetitive movements. Additionally, further analysis of the relationship between lower
leg coactivation and concerns about falling could yield new insight into identifying
individuals at risk of falls.
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CHAPTER 3
METHODS
Study Participants
This study will include three groups: young, older and older impaired adults.
Sixteen individuals between the ages of 21 and 35 years will be recruited for the young
group, and 32 individuals between 65 and 85 years will be recruited for the older groups.
Males and females will be recruited equally. Half of the older participants will have a
mild-to-moderate mobility impairment, as defined by a SPPB score of 8-10 (15), and will
be categorized as “older impaired”. The other half of the older adults will have no
mobility impairments, as defined by a SPPB score of 12. Individuals with an SPPB score
of 11 will still be tested and analyzed post-hoc. All experimental procedures and consent
documents were approved by the University of Massachusetts Amherst Institutional
Review Board.
The participants will be relatively sedentary, participating in no more than 1
structured exercise session > 30 minutes’ duration per week. Individuals will be
excluded if they are currently taking medicine that may affect their physical function.
Those who smoke or have stopped smoking within the previous year will be excluded.
Individuals will be excluded if they have: significant arthritis in the lower extremities, a
pacemaker, a history of muscle cramps or pain, a history of neurological or
neuromuscular disease (including peripheral neuropathy), a history of symptoms upon
exertion (including dyspnea, cramping, and light-headedness), or had a stroke within the
past year. Anyone who has peripheral vascular, cardiac, or pulmonary disease will be
excluded. Individuals with controlled hypertension or hypercholesterolemia will be
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allowed to participate, as will those taking statins, sleep aids or antihypertensive
medications other than beta-blockers. Individuals must score between an 8-12 on the
SPPB in order to participate.
Procedures
Potential participants will be screened by telephone before the visits are
scheduled. Participants will make 2 visits to the Muscle Physiology and Biomechanics
Labs at the University of Massachusetts (Totman Bldg, Rm 22 and 23). Visits will be
scheduled at least 1 but no more than 3 weeks apart. The first visit will be a Habituation
Session lasting 80 minutes (Table 9). The second visit will be the Testing Session, which
will last approximately 90 minutes (Table 10). The participant will be asked to wear
shorts. Standard neutral running shoes (New Balance) will be provided for the participant
to wear on both visits. If the participant wears orthotics, they will be allowed to put the
orthotics in these shoes.
Visit 1: Habituation Session
When participants arrive, they will be led from the foyer of the Totman Building to
the Muscle Physiology Laboratory. The study will be explained in detail and a researcher
will review the Informed Consent document with the participant. If they choose to
participate, the participant will read and sign the Informed Consent document, which
satisfies the requirements of the University of Massachusetts Amherst Institutional
Review Board. They will then fill out a Medical History Form, a Physical Activity
Readiness Questionnaire (74), the FES-I questionnaire (83), and the SF-36 (81);
Appendix).

24

The Medical History Form asks about relevant diseases and medical diagnoses.
This questionnaire is designed to verify that the participant meets all of the inclusion
criteria and does not meet any of the exclusion criteria. The Physical Activity Readiness
Questionnaire is designed to verify that the participant does not have any restrictions
during PA, such as light headedness or pain, and that it is safe for them to engage in PA.
The FES-I asks a series of questions about how concerned an individual is about falling
in a variety of scenarios including during basic and more demanding activities that are
both physical and social. The SF-36 asks about physical and emotional health, and has
questions designed to address if the individual experiences pain in general.
After completing the questionnaires, the participant’s resting blood pressure will
be taken. At this point they will have been seated quietly for at least 10 min. Next, the
participant’s height and weight will be taken using a Detecto-Medic scale (Detecto Scales
Inc, Brooklyn NY). The participant’s body mass index (BMI) will be calculated as
mass/height2 (kg·m-2).
Physical Activity Assessment
Each participant will be given a uniaxial accelerometer (model GT1M, Actigraph,
LLC Pensacola, FL., USA) to objectively record their PA. They will wear the
accelerometer on a belt at their waist for 7 consecutive days, which will provide data
about their activity during the week and weekend. They will be instructed to wear the
accelerometer during all waking hours, except when they are in water. An activity log
will be used by the participant to record their daily activities, sleep schedule, PA bouts,
and any illness and activities outside of their normal activity. They will be instructed to
maintain as normal a PA pattern as possible. This accelerometer is unable to record PA
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from cycling and swimming; therefore participants will be encouraged to record these
activities in their log carefully and avoid them if they are not part of their normal routine.
Data will be collected in 60s epochs and used to determine total activity counts and count
intensity for each day (11). The PA data will be separated into time spent in lowintensity PA (1-1951 counts·min-1, ≤3 METS) and moderate-to-vigorous (≥1952
counts·min-1, >3 METS) based on cutpoints established by Freedson et al. (11).
Physical Function Measures
The participant’s functional ability will then be measured using the normal and
advanced SPPB. The normal SPPB scores the participant from 0-12 based on their
ability to complete specific tasks and will be used to separate individuals into groups (15,
16). The Advanced SPPB (SPPB-A) is an extended version of the test that allows for
more precise scoring and distinguishes between individual who receive a 12, reducing the
ceiling effect of the SPPB (70). A scoring chart for each test can be found in the
Appendix. The chair rise and balance tests will occur in the Biomechanics Lab, and the
walking test will occur in the hallway outside the Muscle Physiology Lab.
First, walking speed will be tested with a 6m walk between 2 lines 6 inches apart
on the floor. The participant will be instructed to walk at a casual walking speed, as if
they were walking down the street, with no criterion of staying between the lines. This
will be done twice and the faster of the 2 walks will be used for analysis. Next, they will
perform the Balance Gait test where they will be instructed to walk between the lines at a
casual speed. This will be performed twice and the fastest time will be used. If they step
outside the lines twice, they will be given a zero on the SPPB-A.
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Next, the participant will perform the chair rise test. They will be led into the
Biomechanics lab where a chair will be set up just off the force platforms so that when
they stand up, their feet are on the force platform (AMTI, Advanced Mechanical
Technology Inc, Watertown MA). The participant will perform 10 chair rises, which
involves standing up from a standardized chair 10 times, as quickly as possible. A split
time will be taken after 5 chair rises. Their arms will be crossed over their chest to
prevent them from being used during the task.
Balance will then be tested on the force platform for 3 foot positions: tandem,
semi-tandem, and side-by-side stance. The participant will be allowed to hold the
researcher’s arm as they are getting into each position. Once they are ready, they will
release their grip and try to hold the foot position for as long as possible, for up to 30s.
The time will be stopped if they move their foot from the position or grasp onto the
researcher’s arm. Testing will begin with the side-by-side stance, where the feet are next
to each other. Next the participant will perform the semi-tandem stance, where the heel
of one foot is placed next to the big toe of the other foot. They will then be tested using
the full tandem stance, one foot directly in front of the other, for up to 30s. The
participant will then stand on one leg for up to 30s, and they will be able to pick which
leg they prefer.
Familiarization
Next, the participant will be introduced to the equipment that will be used during
the Testing Session. In the Biomechanics Lab they will be familiarized with the Humac
Norm dynamometer (CSMi, Stoughton MA). They will lay on the Humac with their leg
fully extended and their thigh and torso strapped to the chair to prevent movement. The
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foot that will be tested will be strapped to the force transducer plate, and their free leg
will rest comfortably on a bar. The participant will practice plantar and dorsiflexion
isometric MVCs. Once they have been familiarized with the MVC protocol, the
participant will then be taken to the foot-tapping station, where they will sit comfortably
in a chair with the ball of one foot resting on an AMTI force platform. The participant
will be instructed on how to tap their foot (lifting the ball of the foot off the ground and
putting it back down as fast as possible). The participant will practice rapidly tapping
each foot for several seconds; this will be done 3-4 times for each foot. They will then
perform 2 10-s FTT on each foot, alternating between legs, during which time the force
platform will record the GRF. The slower leg, as defined by a slower FTS by manual
analysis of the force data, will be used for further analysis.
Stimulated Force Production
In the Muscle Physiology Lab, a stimulating electrode will be placed on the
peroneal nerve, which is about 1 cm distal to the fibular head, of the leg being tested in
order to stimulate the TA. Surface electromyography (EMG) electrodes will be used to
measure muscle activation. A gold-plated disk electrodes (10 mm) for recording EMG
will be placed on the muscle belly of the TA, while another is placed on the distal tendon
of the TA and will be used as a ground. A copper ground plate (6x6 cm) will be placed
half way between the stimulating and EMG electrode to reduce stimulation artifact. The
participant will be seated with their hip at ~180°, knee at ~120° of knee extension, and
ankle at 10° of plantar flexion. Their foot will be securely strapped to a custom designed
platform attached to a force transducer which is used to measure dorsiflexion and plantar
flexion force. The stimulating electrode will be attached to a stimulator (model DS7,
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Digitimer Stimulator, Hertfordshire, UK). All stimuli and EMG recordings will be
obtained using LabView software (National Instruments, Austin TX). The stimulation
intensity will be determined through single twitch stimuli with increasing current until
additional current yield no increase in compound muscle action potential (CMAP). A
current set at 115% of the current needed to elicit a maximal CMAP will be used for
testing. The participant will be told to relax their muscle and three baseline twitches will
be administered with at least 30s in between each of them. The participant will then be
asked to perform 3 isometric dorsiflexion MVCs lasting 3-5s, with a minute rest in
between. During the last MVC, a tetanic train (50 Hz, 0.50s) will be administer when
force is at a plateau in order to calculate CAR. Next, the participant will perform a rapid
contraction with the instruction to reach 40% of peak MVC torque as quickly as possible,
then to relax. A light diode will inform the participant of the percent of their MVC.
They will practice this test until they can reach 40% reliably then perform the test 3
times, with a 30s break in between. A twitch stimulation and a train stimulation (50 Hz,
0.5s) will then be applied while they are relaxed.
Visit 2: Testing Session
At the start of Visit 2, we will collect the activity log and accelerometer and the
participant will then be taken into the Biomechanics Lab where testing will occur. The
protocol will be reviewed with the participant. The participant will warm up by pedaling
lightly on a recumbent cycle ergometer (Schwinn, Nautilus, Inc., Vancouver,
Washington) for 5 minutes, followed by light stretching of the lower extremity muscles,
focusing on the calf and TA.
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EMG Electrode Application
Wireless surface electromyography (EMG) electrodes (Trigno, Delsys Inc, Natick
MA, USA) will then be placed on the belly of the tibilias anterior (TA), medial
gastrocnemius (GM), lateral gastrocnemius (GL), and soleus (SO) muscles of the chosen
leg, using the “Surface Electromyography for Non-Invasive Assessment of Muscles”
guidelines for EMG sensor placement (73). The locations for the GM, GL and SO
electrodes will be identified by asking the participant to stand on their toes, while using a
table to support their weight. The location for the TA will be identified by asking the
participant to dorsiflex against manual resistance. Once the electrode locations have been
determined and marked with a sharpie, a 5x3 cm rectangle will be shaved over each
muscle belly. An alcohol swab will be used to clean the skin and the EMG electrodes
will be adhered to the skin. After the EMG electrodes have been placed on the muscle,
the electrode signal quality will be tested by asking the participant to again stand on their
toes and then to dorsiflex. If necessary, the electrodes will be moved to achieve a better
signal-to-noise ratio, which will be determined by visual inspection, using the Delsys
display, of the difference between the amplitude at the baseline and when the muscle is
contracting. Once a clear signal is achieved, pre-tape wrap will be wrapped around the
leg and electrodes to further secure the electrodes in place.
Muscle Strength Tests
After placement of the EMG electrodes, the participant will be positioned on the
Humac Norm dynamometer to test muscle strength and record EMG activity during
MVCs. The participant will lie on the flat Humac chair as described previously, with the
testing leg fully extended. The leg not being tested will rest comfortably on a bar
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extending from the chair. The participant’s foot will be strapped onto the force
transducer plate, which will be at 10° of plantar flexion. The thigh and torso will be
strapped securely to the Humac to prevent movement, and pads will be placed under the
knee for support.
After the participant is positioned on the Humac, the plantar and dorsiflexion
protocols will be reviewed. The participant will be instructed not to use their knee or hip
to perform the contractions. They will have 2 practice trials of plantar flexion, during
which their torque profile will be visible on the computer. The participant will be
instructed to contract as fast and hard as possible and hold the MVC for 3-5s, with the
goal of having the torque rise quickly and remain level during the MVC. After these 2
practice trials, the participant will perform 3 plantar flexion MVCs. Verbal
encouragement will be provided during the 3 MVCs, and the participant will be
instructed to push the ball of their foot down as hard as possible, as if they were hitting
the gas pedal of a car. Each MVC will last for 3-5s, and the participant will be given 90s
of rest between each trial, to prevent fatigue. Following the plantar flexion protocol, the
procedure will be repeated for dorsiflexion, with the participant having 2 practice trials
followed by 3 test trials. The participant will be instructed to pull their foot up, as if
lifting their foot off the gas, as fast and as hard as possible.
Foot Tap Tests
The participant will rest for 3 min after the MVCs, during which time motion
capture makers will be placed on the leg being studied. The motion capture markers are
retro-reflective spheres of 2 cm diameter that will be placed on anatomical landmarks (5th
metatarsal, medial and lateral malleolus, tibial tuberosity, 1st toe), along with a cluster of
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markers on the heel. The markers will be used to track the motion of the foot during the
FTT. Next, the participant will stand in the anatomical position in the center of the
motion capture collection area on the middle force platform and a 5s static calibration
will be taken. The collection area has 11 Qualysis motion capture cameras (Qualisys,
Gothenburg, Sweden), which will collect data at a sampling rate of 200 Hz.
For the foot tap tests, the participant will sit in a standard chair centered in the
calibrated volume of the motion capture area, about 15 cm behind the force platform,
which is a 60 cm by 120 cm rectangle (Figure 10). The participant will be instructed to
sit comfortably with the middle and ball of their foot on the force platform, but the heel
resting off the platform. When the participant lifts the ball of their foot during the
tapping task, no part of their shoe should be in contact with the force platform. The
participant will be seated with their knee, ankle and hip each at approximately 90° of
flexion. Tape will put on the platform along the edge or top of the participant’s foot as a
visual guideline for the foot’s position. The participant will be instructed to tap their foot
as quickly as possible by lifting the ball of their foot off the platform and placing it back
down. They will be told that in order for a tap to count, their foot must clear the platform
when lifting and make contact with the platform when descending. There will be no
further instructions as to how they should tap their foot, and the participant will be
encouraged to tap in a way that they feel will allow them to produce the fastest speed.
The participant will be instructed to keep their foot resting calmly on the force platform
before and after the collection period in order to obtain a baseline EMG. The participant
will be allowed several brief practice trials of the tapping task before testing begins.
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For all FTTs, force platform data will be collected at a sampling rate of 2,000 Hz
and synchronized with the motion capture data, which will be collected at 200 Hz using
Qualisys Oqus. EMG data will also be synchronized with the force and motion capture
data and collected at 2,000 Hz using Trigno’s recording system. Foot tap speed will be
evaluated 3 ways: 1) research assistant manually counting the number of times, based on
observation and sound, that the foot makes contact with the ground, 2) force platform
recording of GRF, and 3) motion capture cameras tracking the foot markers’ movements.
10-s FTT: The first test will be the 10-s FTT, for which the participant will be
instructed to tap their foot as quickly as possible for 10s. The researcher who is running
the computer will indicate when to begin and end tapping. This FTT will be performed 3
times, with a 60s break between each trial. The average number of taps from the 3 trails
of the 10-s test, as determined by the researcher through visual inspection of the GRF
data, will be used to determine each person’s target speed for the 30%, 60%, and 100%
trials that will follow.
Next, the participant will perform three 10-s trials; 1 at 30%, 1 at 60%, and 1 at
100% of maximal tapping speed. These trials will be used to examine whether muscle
recruitment patterns change at submaximal tapping speeds and if individuals’ ability to
match a speed is impacted by age. To achieve the desired pace, a metronome will be set
at the appropriate cadence and the participant will be given 3, 4 s long trials at the speed
being tested to practice. Once the participant feels comfortable with the task, they will be
given 30s to rest before the trials begin. The participant will perform each 10-s trial
while trying to match the metronome’s cadence. The order of the 30, 60, and 100% trials
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will be randomized between participants and blocked by group. Sixty seconds of rest
will be given between trials. Each speed will be tested once.
Preferred Gait Speed
Participants will walk around 100m around a 20m loop at their preferred walking
speed and data will be collected 3 times as they pass through the collection zone.
Additional trials where the participant walk 10m, starting from a stop, will be given if the
trial speeds are greater than 0.2 m/s different. Both the preferred gait speed walk and the
400m walk will occur in the same space which will consist of 2 cones located 20m apart
on a 22m long raised runway. The runway is 1.2m wide where the participant will be
turning and a research assistant will be positioned to ensure the participant’s safety at all
times. The runway has a collection zone with 11 Qualysis motion capture cameras, and
infrared timing gates which are 6m apart and are used to determine speed. Motion
capture, EMG, and time to complete 6m will be collected each time the participant is
walking to the right through the collection zone.
400m Walk
After completion of the foot tap tests, the participant will have a 5 minute rest
period. An EMG electrode will be taped to the posterior heel of the shoe to determine
timing of heel contact. For the 400m walk test, the participant will be instructed to walk
at a brisk pace that they believe they can maintain the entire time, or to walk as if they
were walking to catch the bus. The 400m walk will consist of 20 laps between two cones
positioned 20m apart. Before the 400m walk, the research assistant will explain the
modified Borg Scale to the participant, which will be used to rate their perceived exertion
before, every 100m during, and immediately after the 400m walk (3). For this scale, a
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“0” indicates an effort level of ‘nothing at all’ and “10” indicates an effort level of
‘extremely strong’ or absolutely maximal.
Following completion of all tests, the markers and electrodes will be removed
from the participant and they will be given a $20 Visa gift card and the option to take
booklets on PA for the aging adult. Any remaining questions will be addressed, and they
will be escorted to their car.
The researchers will call the participants 3 and 6 months after their testing to ask
if they have fallen, or had an unexpected contact with the ground, in the past 3 months,
and if so, how many times.
Data Analysis
Physical function will be determined using the SPPB score and SPPB-A score.
To determine the SPPB score (out of 12), each test (chair rise, walk time, and balance)
will be scored from 0 to 4, with a 4 indicating no impairment for that task (Appendix).
Not all of the tasks described will be used to determine the SPPB score. All of the
described physical function tasks will be used to determine the SPPB-A score, and a
more comprehensive score will be given (Appendix). Individual components of the
physical function measures may also be used for exploratory analyses. Force data
collected during the side-by-side balance stand may be used to examine margin of
stability. Force data collected during the chair rise task may be used to examine
distribution of pressure while standing to see if one leg is providing more of the force
than the other.
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The voluntary and stimulated measures during Visit 1 will provide information on
central and peripheral muscle properties, such as peak torque, RFD, T1/2, CAR. Peak
torque will be determined for the MVC, twitch and tetanus. The maximal RFD (Nm·s-1)
will be defined as the peak dF/dt while the torque is rising and will be determined for the
MVC, 40% of MVC contractions, twitch and tetanus (50Hz, 0.5ms) contraction. Half
relaxation time (T1/2, ms) will be determined from the tetanus and will be defined as the
time it takes for the torque to fall 50% after the last stimulation. The CAR will be
determined from the superimposed tetanus during the MVC, with an increase in force
during stimulation indicating a deficit in central activation. A twitch will be administered
at the end of the collection to determine if there was any potentiation from the trials.
Data collected during the muscle strength tests on the Humac Norm will be:
isometric plantar and dorsiflexion torque, and EMG activity during maximal contractions.
The highest torque for plantar and dorsiflexion, identified using a MatLab program, from
each set of 3 trials will be used to determine the participant’s MVC for each task. The
average rectified and integrated EMG signal for a 1-s window during maximal torque
production from the highest MVC will be used as peak EMG (mV), which will be used
for CoActM normalization.
The FTTs will be analyzed using a Matlab program which will be written to
analyze the force platform data and determine how many times the foot made contact
with the platform based on a deviation of force from the baseline, and through this
method, count the number of taps. This Matlab program will also be used to quantify
several dynamic variables that will capture tapping patterns. These will include the ITI

36

(ms), as well as the average, standard deviation and coefficient of variation of the ITI,
and the average, standard deviation, and coefficient of variation of the GRF.
Visual 3D (C-Motion) will be used to track the motion of the markers during all
FTTs, and each time the participant is walking to the right during the preferred gait and
400m walk. The heel accelerometer will be used to identify foot contact during both
walking trials. 6Motion capture data collected during the FTTs and gait trials will be
analyzed by a Matlab program that will use the angle of the ankle and the foot’s velocity
to separate the motion into dorsiflexion and plantar flexion time segments. With this
information, the EMG data will be separated into dorsiflexion and plantar flexion time
segments, and the agonist and antagonist activity for each period will be quantified to
determine CoActM, while the onset and offset time of the muscles will be used to
determine CoActT.
The EMG data for visit 2 will be collected at a sampling rate of 2,000 Hz during
the MVCs, foot tap tests, preferred gait, and 400m walk. Data will be rectified and
filtered with a Butterworth filter, then integrated to determine the amount of muscle
activity. The EMG data from the FTT, preferred gait, and 400m walk will be normalized
to the maximal activity recorded when the muscle was acting as an agonist muscle during
the MVC tests on the Humac Norm. The normalized antagonist and agonist activity for
each task will be used to determine CoActM based on Equation 1.
Preferred and brisk gait speed (400m walk) will be determined using the timing
gates 6m apart (m·s-1). Walking speed will be quantified at each lap, or 10 times, during
the 400m walk, to examine how the participant’s speed changes during the endurance
walk. The total time required to complete the 400m walk is will also be recorded. If the
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participant needs to rest during the study, which they will be encouraged not to do, the
duration of time they rest will be recorded and added to the total walk time but will not be
used in the calculation of 400m walk speed.
Statistical Analyses
Statistical Analysis Software, version 9.3 (SAS Institute Inc., Cary, NC) will be
used for all statistical analyses (Table 11). A p value of 0.05 will be used to establish
significance for all analyses. Differences between descriptive variables (age, height,
body mass, BMI, BP, SPPB and SPPB-A score, PA counts and count intensity, 400m
walk time, preferred and brisk gait speed, plantar and dorsiflexion MVC torque, maximal
rate of torque development, T1/2, CAR, FES-I, fall occurrence at follow up) of the groups
will be evaluated using Analysis of Variance (ANOVA). These variables may be used as
covariates in the primary analyses if statistical difference is found. To address the first
aim, ANOVA tests will be used to determine whether there is a difference in FTS,
CoActM, and CoActT during the 10s-FTT between the young, older, and older impaired
groups. A regression analysis will be applied to the CoActM and FTS data for all of the
older adults, combined. The second aim will be addressed through an ANOVA of
CoActM during the first three laps of 400m walk in all 3 groups, and a linear correlation
between CoActM and gait speed will be performed using the data for all older adults,
combined. The second aim also includes exploratory regression analyses of CoActM and
gait speed variability during the 400m walk and FES-I score for all older adults,
combined. The final, exploratory aim will be addressed by analyses of the dynamic
variables, such as ITI, GRF, toe excursion and number of foot taps during a 10s period, to
examine foot tapping patterns during the 10s and 90s FTT. This aim will also be
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addressed by analyses of the dynamic variables during the constrained (30, 60 and 100%
of maximal FTS) conditions.
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Revisions from original proposal
The aims of the study have been adjusted slightly based on the methods that were
analyzed. A subset of the data collected were analyzed and presented here in order to
address a more cohesive question.
Coactivation during the 400m walk and at preferred walking speed are not
presented in this paper, but will be analyzed later. The relationship between coactivation
during gait and fear of falling are also not presented. Additionally, data were collected
while participants tapped to a metronome which was set at 30, 60 and 100% of the
participant’s foot tap speed to address exploratory Aim 3.2. These data are not included
in this thesis but will be analyzed in the future to look at variability while tapping to a
rhythm.
The purpose of this study was to investigate the potential causes of slowed foot
tap speed in older adults, determine whether mobility function is related to slowed
tapping, and explore the relationship between foot tap speed and physical function in
older adults. The following hypotheses were tested (Figure 1A):
Hypothesis 1. Greater performance variability during the FTT is related to slower
foot tap speed
1.1 Performance variability (COV-ITI) during the FTT will be greater in
higher and lower functioning older adults than young adults
1.2 COV-ITI will be negatively associated with FT count in older adults
Hypothesis 2. Greater muscle coactivation during the FTT is related to slower foot
tap speed
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2.1 Muscle coactivation during the FTT will be greater in higher and lower
functioning older adults than young adults
2.2 Coactivation will be negatively associated with FTC in older adults
Hypothesis 3. Slower contractile properties of the dorsiflexor muscles is related to
slower foot tap speed.
3.1 Young adults will have faster rates of force development and relaxation in
the dorsiflexor muscles during the stimulated and voluntary submaximal
contractions than both older groups
3.2 The rate of force development in the dorsiflexor muscles will be positively
correlated with FTC in both young and older adults
3.3 The rate of force relaxation in the dorsiflexor muscles will be negatively
correlated with FTC in both young and older adults
Hypothesis 4. Foot tap speed will be related to usual walk speed, 400m walk speed, and
SPPB-A, in older adults
4.1 FTC will be positively associated with physical function in older adults
4.2 COV-ITI will be negatively associated with physical function in older
adults
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CHAPTER 4
EXPANDED MANUSCRIPT

Introduction
Beginning around the 7th decade of life, there are changes that occur within the
neuromuscular system that can lead to a decline in physical function. Among other
things, alteration in the neuromuscular system include changes in overall control of
movement, muscle activation patterns, and muscle contractile speed.
Rapid repetitive tapping tests, such as a 10s foot tapping test (FTT), have been
used by neurologists to track changes in central nervous system (CNS) disease as
individuals with diseases affecting the CNS are unable to perform rapid foot tapping as
quickly as healthy individuals (14, 27, 51, 58, 59, 76). The FTT has also been used in the
study of neuromuscular function in aging (29, 59, 76). Studies have shown that older
adults are unable to perform rapid foot tapping as quickly as young adults (29, 59). This
slowing of foot tap speed holds true even when young and older adults have comparable
muscle strength per unit mass (i.e specific strength), central control of rate of force
development, and voluntary activation of their ankle dorsiflexor (DF) muscles (29). The
cause of slower foot tap speeds in older adults is still not known.
Rapid tapping requires the rapid recruitment and relaxation of the muscles
involved in the action. Therefore, the speed of muscle activation can impact how quickly
the task is performed. Muscle contractile properties, such as the rates of force
development and relaxation, can limit the overall speed of a movement during repetitive
tasks. Kent-Braun et al. found that older adults did not have a deficit in
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voluntary:stimulated RFD, indicating no impairment in central conduction speed of the
DF muscles during submaximal, rapid contractions; however, the older adults still had a
slower foot tapping speed, a potential indicator of slowing within the CNS (29). Older
adults have been shown to have slower RFD and RFR in the DF muscles than younger
adults when elicited by a stimulated contraction (57). The slowing of voluntary RFD and
RFR of the DF have not been studied in conjunction with changes in rapid tapping
performance. Thus, it is unknown whether slowing of the DF muscle during voluntary
contractions impairs foot tap speed.
Poor control of repeated muscle activations could also limit the speed of rapid
tapping, by means of increased coactivation and greater motor variability. Coactivation
is defined as activation of the antagonist muscle during agonist activation. Greater
muscle coactivation has been observed at faster movement speeds (23, 48). Muscle
coactivation of the lower extremities has been found to be greater in older than young
adults but there are inconsistencies in the literature specifically regarding shank
coactivation (22, 38, 53, 64, 66). Some investigators have found that shank coactivation
does not differ between old and young adults while walking (10, 64), or when performing
isometric, concentric, or eccentric contractions (32), while others report greater shank
coactivation during gait (22, 53, 66) and static standing (40, 53). It remains unclear
whether coactivation could be a cause of slowed repetitive tapping in older adults.
A change in central motor drive could result in more variability in performance,
and potentially contribute to the slowing of foot tapping speed. One way to determine
tapping variability is the coefficient of variation of the timing between taps (COV-ITI).
Older adults have been shown to have greater COV-ITI during rapid finger tapping, and
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in both young and older adults, variability in tapping increased when tapping frequency
increased (71). However, a study by Tomita et al., examined performance variability
while foot tapping at a fixed speed and found that COV-ITI was not correlated with foot
tapping speed in healthy older adults, but was correlated in individuals who had had a
stroke (76). While the FTT and variability were not tested simultaneously, the variability
seen in stroke patients but not healthy individuals might suggest that greater variability in
tapping performance could be indicative of poor motor control.
Several functional tests have been validated for identifying older adults with
declining physical function, including gait speed, 400m walk time, the Short Physical
Performance Battery (SPPB), and the SPPB-A (15, 70, 72, 80). Speed of rapid, repetitive
foot-tapping has been linked to physical function in individuals with cervical myelopathy
(59), but few studies have examined its relationship to function in older adults. A
longitudinal study of older women by Kent and colleagues (unpublished results) found
that slower tapping speed at baseline predicted a decline in gait speed, and thus mobility,
at a two year follow-up. These results suggests that the slowing of foot tap speed may
precede changes in physical function.
The purpose of this study was to investigate the potential causes of slowed foot
tap speed in older adults, determine whether mobility function exaggerates the causes of
slowed tapping, and explore the relationship between foot tap speed and physical
function in older adults. The following hypotheses were tested (Figure 1A):
Hypothesis 1. Greater performance variability during the FTT is related to slower
foot tap speed
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1.1 Performance variability (COV-ITI) during the FTT will be greater in
higher and lower functioning older adults than young adults
1.2 COV-ITI will be negatively associated with FT count in older adults
Hypothesis 2. Greater muscle coactivation during the FTT is related to slower foot
tap speed
2.1 Muscle coactivation during the FTT will be greater in higher and lower
functioning older adults than young adults
2.2 Coactivation will be negatively associated with FTC in older adults
Hypothesis 3. Slower contractile properties of the dorsiflexor muscles is related to
slower foot tap speed.
3.1 Both older adults will have a slower rate of force development and
relaxation in the dorsiflexor muscles during the stimulated and voluntary
submaximal contractions than Young adults
3.2 The rate of force development in the dorsiflexor muscles will be positively
correlated with FTC in both young and older adults
3.3 The rate of force relaxation in the dorsiflexor muscles will be negatively
correlated with FTC in both young and older adults
Hypothesis 4. Foot tap speed will be related to usual walk speed, 400m walk speed,
and SPPB-A, in older adults
4.1 FTC will be positively associated with physical function in older adults
4.2 COV-ITI will be negatively associated with physical function in older
adults
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Methods
Study Design
Participants were tested at two visits, with approximately one week between each
visit. The first visit included informed consent, anthropometrics, questionnaires, the
SPPB and SPPB-A, usual walk tests, familiarization protocols, foot tapping tests on both
legs, and stimulated and voluntary contractions to measure contractile properties of the
DF of the slower leg. The second visit consisted of electromyography (EMG)
measurements of the tibialis anterior, medial and lateral gastrocnemius, and soleus
muscles of the slower leg during: DF and plantar flexion (PF) maximal voluntary
isometric contractions (MVICs), foot tapping, and the 400m brisk walk; motion capture
was record during the latter two tests. A physical activity monitor was worn between the
first and second visit to assess habitual activity behavior.

Participant Characteristics
Eighteen young (9F) and 28 older (14 F) healthy adults were recruited. All
participants were healthy, and self-reported as being free of any diseases that affected the
central nervous system or blood flow. All participates were nonsmokers and were not
taking any medication that impacted muscle function. Participants were sedentary to
recreationally active. Informed consent, approved by the Institutional Review Board at
the University of Massachusetts Amherst, was obtained for all participants.
Participants completed the Short Form-36 (SF-36), a short questionnaire which
asks about physical and emotional health, and assesses whether the individual
experiences general pain (81). Participants also completed the Falls Efficacy Scale-
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International (FES-I), which asks a series of questions about how concerned an individual
is about falling in a variety of scenarios (83).

Physical Activity (PA)
Participants wore a uniaxial accelerometer (model GT1M, Actigraph, LLC
Pensacola, FL., USA) on their right hip during all waking hours for 7 days. Participants
kept a log of their activity to enable detailed manual inspection of the accelerometry data.
They were instructed to maintain as normal a PA pattern as possible. A minimum of 5
days with at least 10 hours of wear time each was needed for analysis, with one of the 5
days being a weekend day. Data was collected in 60s epochs and separated into time
spent in low-intensity (1-1951 counts·min-1, ≤3 METS) and moderate-to-vigorous (≥1952
counts·min-1, >3 METS) PA based on cutpoints established by Freedson et al. (11).
Counts, minutes of moderate to vigorous physical activity (MVPA) per week, and percent
of wear time in activity (minutes of light + MVPA divided by minutes of wear time, %)
were determined.

Physical Function
Physical function was determined using the SPPB, SPPB-A, usual walking speed,
and 400m brisk walking speed (15, 70). The SPPB is a common functional test that
scores individuals from 0-12 based on their ability to complete 3 tasks: time to complete
a 4m walk at a preferred walking speed, ability to balance for 10s in 3 positions (tandem,
semi-tandem, side-by-side stance), and time to complete 5 chair rises (15, 16). The
SPPB-A (appendix) is an expanded version of the SPPB, scored continuously from 0-4,
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which allows for more precise scoring and distinguishes among relatively high
functioning individuals who receive a 12, thus reducing the ceiling effect inherent to the
SPPB (70). The older adults were separated into higher (HFO) and lower (LFO)
functioning groups based on their performance on the SPPB-A (70). The median value
for women, 2.47, and the median value for men, 2.59, were used to divide the older
adults, by gender, into 2 groups. Each group had 14 participants, 7 of which were
women.
Usual gait speed was determined during two 6m walks in the hallway, with the
average speed during these 2 trials used for subsequent analysis. For the 400m walk, 2
cones were set up 20m apart in the Biomechanics Lab. Motion capture, force data, EMG
and time were recorded in a 6m space approximately half way between the cones. The
400m walk consisted of 10 laps around the 2 cones, during which participants were
instructed to walk at a brisk walking speed, and the verbal cue of “walk quickly as if you
were trying to watch a bus” was given each lap. Total time to complete the 400m walk
was determined.

Foot Tap Test
For the FTT, the participants were seated in a standard chair about 15 cm behind a
60 x 120 cm force platform (AMTI, Advanced Mechanical Technology Inc, Watertown
MA, sampling rate 2,000 Hz). The participants were seated comfortably with their hip
and knee at approximately 90° of flexion, the middle and ball of their foot on the force
platform, and their heel resting off the platform (Figure 2A and 1B). Participants were
positioned so that their shoe was not in contact with the force platform when the ball of
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their foot was lifted. This placement produced distinct peaks for each tap during the FTT,
as shown in Figure 2C. The participants were allowed several brief practice trials before
testing began. For each trial, the participants were instructed to tap their foot as quickly
as possible for 10s.
During the first visit, each participant performed the FTT on each leg at least two
times, in a randomized, alternating order, and only force data was recorded. The foot tap
count (FTC) from the fastest trial of each leg was determined. The leg with the lower
FTC, or rather the slower leg, was subsequently tested for contractile speed and EMG.
During the second visit, the FTT was performed again on the slower leg and
motion capture and EMG data were collected in addition to force data. Retro-reflective
markers were placed on the 1st and 5th metatarsal, medial and lateral malleolus, tibial
tuberosity, 1st toe, along with a heel cluster (Figure 2A and B). The collection area had
11 Qualysis motion capture cameras (Qualisys, Gothenburg, Sweden) set to collect data
at a sampling rate of 200 Hz.
Force platform data from the FTT was analyzed with a MATLAB program that
identified a tap as a local force maxima, calculated FTC as the sum of local maxima
during the 10s trial, determined the timing between taps (intertap-interval, ITI) and
calculated the variability of tap timing (COV-ITI) during the 10s trial (Figure 2C and
Figure 3).

EMG
Wireless surface EMG electrodes (Trigno, Delsys Inc, Natick MA, USA) were
placed on the belly of the tibilias anterior (TA), soleus (Sol), medial gastrocnemius (MG),
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and lateral gastrocnemius (LG) muscles of the slower leg during the second visit
following established guidelines (73). Before being placed, the skin was shaved with a
razor and cleaned with alcohol swabs.
Maximal muscle activity for EMG normalization was achieved during DF and PF
MVICs on a Humac Norm dynamometer. Participants were positioned with their foot at
10° of PF, their knee at approximately 160°, and their hip at approximately 170°.
Participants completed three, 3-5s MVICs of PF with 90s of rest between trials. Verbal
encouragement was provided during each MVIC. If two of the MVICs differed by more
than 10%, the participant preformed a 4th MVIC. The same protocol was used for the DF
MVICs. Electromyography was recorded for each muscle group during the MVICs, and
the MVIC trial with the greatest peak torque was used for EMG normalization.
The EMG signal was rectified, bandpass filtered between 20 Hz and 500 Hz, and
normalized to the average EMG signal collected for 0.5 seconds during peak torque of
the DF and PF MVICs. The muscle activation ratio (Act-R) during the FTT was
calculated to examine the overall activation of the TA, or agonist, relative to the plantar
flexor, or antagonist, muscles and is defined as:
𝐴𝐴𝐴 − 𝑅 =

𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼 𝑇𝑇 𝑁𝑜𝑟𝑟 𝐸𝐸𝐸 (% 𝑜𝑜 max)
1
∗
𝐴𝐴𝐴𝐴𝐴𝐴𝐴 𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼 𝑁𝑁𝑁𝑁 𝐸𝐸𝐸 (% 𝑜𝑜 max) 𝑜𝑜 𝑆𝑆𝑆, 𝑀𝑀, 𝐿𝐿 𝐹𝐹𝐹

For the FTT, the normalized EMG signal for each muscle was integrated over the 10s of
tapping, and normalized to the length of the test (10s) and the number of taps. This
yielded an integrated, normalized EMG value per tap for each muscle group which was
used to calculate Act-R. An Act-R value greater than one indicates greater relative
activation of the tibialis anterior than the plantar flexor muscles.
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Coactivation during the FTT was calculated by determining the correlation
between the agonist and antagonist’s EMG signals. Correlation during the 10s of the FTT
was calculated based on the agreement in timing and shape of the EMG signals for the
TA and Sol, which were first normalized to the EMG during the MVIC. The Sol was
chosen for this analysis because it is the most active PF muscle when the knee is bent
(69). A value of 1 indicates that the EMG signals are identical and a value of 0 indicates
no agreement in the timing and shape of the TA and Sol signal; thus greater coactivation
was indicated by a correlation coefficient closer to 1. Custom MATLAB codes were
written to process and analyze the EMG data. Specifically, EMG data was rectified, band
pass filtered between 20-500 Hz, then normalized to EMG during the MVIC. Data was
then run through the Act-R algorithm and the EMG correlation analysis. A time lag
value was not calculated for the EMG correlation analysis measure. The EMG data was
corrupted for one HFO and they were excluded from EMG analysis.

Contractile Speed
Contractile speed of the TA muscle of the slower leg were examined using
voluntary and stimulated contractions. A stimulating electrode, attached to a stimulator
(model DS7, Digitimer Stimulator, Hertfordshire, UK), was placed on the peroneal nerve,
about 1 cm distal to the fibular head to stimulate the TA. A gold-plated disk electrode
(10 mm) was placed on the muscle belly of the TA, determined during maximal DF, to
record the EMG, and another acted as a ground and was placed on the distal tendon of the
TA. A copper ground plate (6x6 cm) was placed half way between the stimulating and
EMG electrode to reduce stimulation artifact. The participant was supine with their hip
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at ~120°, knee at ~40° of knee flexion, and ankle at 10° of plantar flexion. Their foot
was securely strapped to a custom designed platform attached to a force transducer which
is used to measure DF force, and the knee was strapped down to reduce movement
artifact. All stimuli and EMG recordings were obtained using LabView software
(National Instruments, Austin TX). The stimulation intensity was determined through
single twitch stimuli with increasing current until additional increases in current yield no
increase in the compound muscle action potential. A supramaximal current (115% of the
current associated with the compound muscle action potential) was used for subsequent
stimulations.
Three baseline twitches were administered while the participant was relaxed and
at least 30s rest was given between each of them. The participant then performed 4 DF
MVICs lasting 3-5s, with a one min rest between each trial. During the last MVIC, a
tetanic train (50 Hz, 0.50s) was administered when force had plateaued in order to
calculate central-activation ratio (CAR). Next, the participant performed voluntary rapid,
submaximal isometric (ballistic) contractions as quickly as possible with the target of 3060% of peak MVIC force; a light diode box was used for visual feedback and verbal
encouragement was given. Participants performed 3 trials, each consisting of 3 rapid
contractions, and trials with peak force outside of the range of 30-60% of peak MVIC
force were excluded from analysis. Thirty seconds of rest was given between trials. After
a 1 min break, a tetanic train (50 Hz, 0.5s) and twitch stimulation were applied in quick
succession while the participant remained fully relaxed.
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The CAR was calculated as a rise in force when a tetanus stimulus was applied
during a maximal voluntary contraction. If force did not rise, the CAR was determined to
be 1. If force increased, the amount of central failure was calculated as:
𝐶𝐶𝐶 =

𝑃𝑃𝑃𝑃 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 𝑓𝑓𝑓𝑓𝑓 (𝑁𝑁)
𝑃𝑃𝑃𝑃 𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣 𝑓𝑓𝑓𝑓𝑓 (𝑁𝑁)

Voluntary slope and Maximal Rate of Force Development (Max RFD) and
Relaxation (Max RFR) were calculated for the ballistic contractions, and Stimulated Max
RFD and RFR were calculated for the twitch contractions. For all contraction types, Max
RFD and RFR were calculated by first normalizing the force values to peak force of the
contraction, then the greatest instantaneous rate of force development or relaxation was
determined; in other words, Max RFD and RFR occurred when the second derivative
crossed zero. Slope of force development and relaxation were calculated for the ballistic
contractions as the change in force and time from the start of force development to the
peak force, or from peak force to the return of force to baseline. Slope of force
development and relaxation were not determined for the twitch contractions. Figure 4
illustrates the analysis of Slope and Max RFD from a ballistic contraction.
Twitch contractions were used to examine twitch force and M-wave
characteristics, or the muscle response to a single electrical stimulation. In addition to
Stimulated Max RFD and RFR, time to peak force and half relaxation time (T1/2) were
calculated from twitch force. The M-wave duration was calculated as the length of time
the TA muscle took to transmit the action potential, or duration of the negative peak plus
the positive peak. The M-wave amplitude was calculated from the difference in mV
between the negative and positive peak, while the M-wave negative peak was the
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difference in mV between baseline and the negative peak. Twitch and M-wave
characteristics were calculated from the average of three twitch contractions.

Statistics
A one-way ANOVA was used to compare the three groups for Hypotheses 1.1,
2.1, and 3.1. When significant main effects were found, Tukey’s post-hoc analysis was
performed to identify differences between groups. Data that were not normally
distributed were tested with a Kruskal-Wallis test. To address Hypotheses 1.2 and 2.2,
regression analysis was performed between FTC and potential mediators of slowed foot
tap speed in all of the older participants. To address Hypothesis 3.2, regression analysis
was performed between contractile speed and FTC in the young and older participants
separately. A regression analysis was performed in order to examine the relationship
between FTC and COV-ITI and physical function in all of the older participants for
Hypotheses 4.1 and 4.2. Multiple regression analyses were used to determine which
measures physical functions had the largest influence on FTC for the older participants.
An alpha value of 0.05 was used to establish significance.
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Results
Participants
Physical function and physical activity measures are summarized in Table 1. The
HFO group was younger than the LFO. The SPPB-A differed across groups such that
Young>HFO>LFO. For the SPPB, all Young scored a 12, eleven HFO scored a 12, and
three HFO scored an 11. The LFO had SPPB scores ranging from 8-12 with a median
value of 11. The three groups differed in usual walk speed, and post-hoc analysis
revealed that LFO was slower than HFO and Young. The 400m brisk walking speed
differed across groups such that Young>HFO>LFO; one HFO was excluded from
analysis because his 400m walk speed was greater than two standard deviations above the
mean speed for the HFO. For the SF-36, physical function, energy and fatigue, pain, and
total score were examined and significant main effects between groups were found. Posthoc analysis revealed that LFO scored worse than Young on the physical function
questions. For their energy and fatigue score, the HFO>LFO>Young, with a lower value
indicating greater fatigue. Post-hoc analysis of the pain scores indicated that LFO
experienced greater pain, in general, than HFO. The overall composite score for the SF36 was greater for HFO than LFO and Young. The groups did not differ in BMI or FES-I
score.
On average, participants wore their physical activity monitors 14.3 hours per day
(14.2±1.3 hrs for Young, 15.0± 1.1 for HFO, 13.8±1.0 for LFO), for 6.7 ±1.0 days.
There was a significant main effect across groups for daily PA counts and MVPA; post
hoc analyses indicated that LFO had fewer counts and both HFO and LFO had fewer
minutes of MVPA than Young. All three groups spent a comparable percentage of wear
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time in activity. One HFO woman was excluded from PA analysis because she was
greater than two standard deviations about the HFO’s mean for minutes of MVPA. She
was not excluded from other calculations because she was not an outlier for any other
metric.

Foot Tap Variability
Figure 3 shows examples of 10s of foot tap data from representative individuals in
the Young (3A), HFO (3B) and LFO (3C) groups whose COV-ITI for the faster foot was
close to the group mean. Group data for the FTT are presented in Table 2. For the faster
foot, there were main effects for group for FTC and variability of tap timing (COV-ITI),
with post hoc tests revealing slower tap speed in LFO compared with Young and HFO,
and greater COV-ITI in Young than LFO (p<0.05). There were no differences between
groups in FTT variables for the slower foot (second visit).

Muscle Activation
Figure 5 shows sample EMG data from the four muscles during the FTT. Muscle
activation for each muscle during the FTT, relative to activation during the MVIC,
showed a main effect between groups. Post-hoc analyses revealed that HFO and LFO had
greater activation of their TA and MG than Young during the FTT, and HFO also had
greater relative activation of the Sol and LG than Young (p<0.05, Table 3). The groups
did not differ in average Act-R during the FTT, but Young had a higher correlation
coefficient than HFO during the FTT, indicating greater coactivation (p<0.05). Figure 5,
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panels B and C, show EMG data for a representative Young (5B) and HFO (5C) adults;
participants whose correlation coefficients were close to the group means were selected.
Maximum EMG signals were recorded during MVIC performed on the Humac
Norm dynamometer. There was a main effect for DF and PF force during the MVICs;
post hoc analysis revealed that Young and HFO produced more force during DF trials
than LFO, and Young produced greater PF force than LFO (p<0.05). Specifically, the
Young adults produced an average PF force of 75.8 ± 22.8 Nm and DF force of 37.6 ±
10.3 Nm; HFO produced an average PF force of 56.4 ± 18.7 Nm and DF force of 36.7 ±
11.4 Nm; and LFO produced an average PF force of 56.9 ± 27.1 Nm and DF force of
26.8 ± 8.7 Nm. While MVIC force varied by group, the EMG amplitude during the
MVICs, which were used for normalization, did not differ between the groups for any of
the muscles (p>0.05).
No participants in Young or HFO showed central activation failure, thus they
were able to fully activate their TA muscle; CAR values were 1.00 ± 0.00 for Young
(n=14) and HFO (n=14). Two individuals in LFO had central activation failure, with
CAR values of 0.90 and 0.92; the overall group average for LFO was 0.99±0.04 (n=12).
Peak MVC torque recorded on the DF apparatus did not differ between groups and was
43.4 ± 11.7 (n=18), 35.8 ± 9.1 (n=13), and 35.2 ± 7.0 Nm (n=14) for Young, HFO, and
LFO respectively.

Contractile Speed
For the voluntary ballistic contractions, the only measure that differed between
groups was the slope of force development, with post-hoc analysis revealing that Young
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had a faster slope of force development than LFO (Table 4). Force produced during these
contractions did not differ across groups.
Twitch and M-wave characteristics are reported for a subset of participants due to
difficulties during data collection, Table 5. Peak twitch force and time to peak force were
the only twitch characteristics that differed between groups. Post-hoc analyses revealed
that HFO had a lower peak twitch force than Young, and that LFO had a longer time to
peak force than Young (p<0.05). There were significant differences between the groups
for the M-wave properties. Post-hoc analyses revealed that Young had a greater M-wave
amplitude than HFO and LFO, and a greater M-wave negative peak than HFO (p<0.05).
Twitch and M-wave data were excluded if stimulation was not done (n=2), or if
twitch force was less than Nm (n =11). One HFO male was excluded from the
calculations of voluntary and stimulated contractile speeds. The data from this
participant were greater than 2 standard deviations above the mean DF force, slope of
force development and relaxation for the HFO group. However, these data are included
for all other analyses because the FTC for each leg and each of the functional measures
were less than two standard deviations above the average for the HFO group. One
possible explanation for the higher DF force and faster contractile speeds in this
individual is that he is a drummer, an activity that trains the DF muscles.

Associations between Foot Tap Characteristics and Potential Moderators
Associations between FTC and variability of tapping (COV-ITI), coactivation,
and muscle contractile speed were examined for the older participants and data are
presented in Table 6. The FTC of the faster leg was not correlated with COV-ITI during
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the same trial (p=0.517, r2=0.016), nor was FTC of the slower leg correlated with COVITI in the older participants (Table 6).
Within the older participants, there was not an association between FTC and
muscle activation, Act-R, for the same trial (Figure 6A). Foot tap count and the
correlation coefficient during the same FTT were negatively associated (r2=0.273,
p=0.005) in the older participants (Figure 6B). The Act-R and correlation coefficient
were not related in the older participants (r2=0.061, p=0.214).
There was no significant relationship between FTC and slope of force
development and relaxation during the ballistic contraction for the older participants
(Figure 7 B and D). However, there was a relationship between FTC and Max RFD and
RFR in the older participants (Figure 8 B and C). Foot Tap Count and MVIC force were
not associated in the older participants (p=0.387). The Young adults’ FTC was strongly
associated with slopes of force development (r2=0.523, p <0.001) and relaxation
(r2=0.394, p<0.005) during the ballistic contractions, as seen in Figure 7 A and C. The
Young adults’ FTC was also positively associated with Max RFD (r2=0.245, p=0.037,
Figure 8A) and with MVIC force (r2=0.476, p=0.001).
Associations between Foot Tap Count and physical function in the older
participants were examined and results are presented in Table 7. Foot tap count from the
faster leg was positively correlated with SPPB-A score (r2=0.329, p=0.001, Figure 9A), ,
and MVPA (r2=0.182, p=0.023, Figure 9C) in the older participants. Foot tap count of
the faster leg was not correlated with 400m brisk (p=0.176, Figure 9B) or usual walking
speed (p=0.094). Foot tap count from the faster leg was negatively correlated with age
for the older participants (r2=0.277, p=0.004, Figure 9D). Foot tap count of the slower
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leg from visit 2 was positively correlated with MVPA (r2=0.158, p=0.036), but not with
SPPB-A (p=0.084), usual walk speed (p=0.633), 400m walk speed (p=0.108), or age
(p=0.441) in the older participants.
The COV-ITI of the faster foot was not associated with any measures of physical
function or age (Table 8). The COV-ITI of the slower foot was positively associated with
SPPB-A score (r2=0.181, p=0.024) and usual walking speed (r2=0.202, p=0.017), but not
with 400m walk speed (p=0.212), MVPA (p=0.887) or age (0.248).
A step-wise multiple regression analysis of the impact of age + SPPB-A score on
FTC of the faster foot was significant (r2=0.413, p=0.0013), but only SPPB-A contributed
significantly to this association (p=0.024). A multiple regression analysis was also run to
examine the impact of age, SPPB-A score, MVPA, and 400m walk speed on FTC of the
faster foot. The regression was significant (r2=0.482, p=0.0034) with all four variables,
but only SPPB-A contributed significantly (p=0.023).
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Discussion
The main purpose of this study was to determine whether increased performance
variability (COV-ITI), greater muscle coactivation, or slower muscle contractile
properties are associated with slowed foot tap speed in older adults (Figure 1A). Overall,
lower FTC in older adults was related to greater muscle coactivation, determined by
correlation analysis of the EMG signals, and slower Max RFD and Max RFR. However,
FTC was not related to COV-ITI in older adults (Figure 1B). Higher FTC was associated
with faster voluntary contractile speeds in Young adults (Figure 1C). The secondary
purpose was to determine if FTC and COV-ITI were related to physical function in older
adults. The data showed that FTC of the faster foot was related to SPPB-A score, a
composite measure of physical function, in older adults. Contrary to what was
hypothesized, the COV-ITI of the FTT on the slower leg was positively associated with
SPPB-A and usual walking speed, with a lower COV-ITI related to worse physical
function.

Foot Tap Variability
Hypothesis 1.1 was not supported by the data, as Young adults had a greater
COV-ITI than LFO, but COV-ITI did not differ between Young and HFO. The COV-ITI
was not related to FTC in the fastest trial from either the faster or the slower foot in older
adults. This result suggests that variability in performance of the FTT does not limit foottapping speed in older adults. This result is not in agreement with findings from other
studies which found greater variability with age, but those studies were examining
variability while tapping to a set metronome speed (71, 76). The FTT does not supply a
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rhythm for participants to match but rather allows participants to employ whatever
tapping method yields the best results, and greater tapping variability did not negatively
affect performance for this metric.
A smaller COV-ITI score in the LFO group could indicate a more diseased state
as a reduction in movement variability has been associated with diseased states (18).
Findings from our study support the idea that there is reduced variability in a diseased
state as COV-ITI of the slower foot was positively related to SPPB-A and usual walking
speed. These data suggest that those with lower physical function tended to have less
variability while tapping their slower foot. Thus a smaller COV-ITI during the FTT
could indicate a movement impairment that is not seen in healthy older adults.

Muscle Activation
Muscle coactivation was hypothesized to be greater and to negatively affect foot
tap speed in older adults. Overall, muscle activation was greater in HFO than Young for
each muscle, and greater in LFO than Young for the TA and MG muscles. To calculate
muscle activation, EMG data during the FTT were normalized to muscle activation
during MVICs. The Act-R, a ratio indicating the relative magnitude of DF:PF muscle
activation during the whole 10s trial, did not differ between the groups. The Act-R was
normalized to the number of taps to remove the possibility of a bias based on FTC. The
HFO had the closest Act-R value to one, indicating that their PF muscles were more
active relative to their TA muscle; one possible explanation for the greater relative PF
activity is that HFO had greater PF activation between each tap, potentially helping the
foot return to the ground. Figure 5 helps to visually support this hypothesis, showing a
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HFO individual with PF activity between each TA burst and an Act-R of 1.24 (5C). The
EMG data in Figure 5B shows a Young adult who had smaller PF activity between taps
and an Act-R of 2.21, indicating greater DF activation relative to PF activation. The ActR per tap does not indicate how much the TA and PF muscle activity overlapped, but a
correlation analysis does.
Here, EMG correlation analysis indicated how much the timing of the TA and Sol
signals were in agreement during the FTT; a larger correlation coefficient indicates
greater coactivation. Relative to EMG collected during an MVIC, the Sol was the most
active PF muscle during the FTT (Table 3). Previous studies have also shown that the
Sol is more active during rapid DF tasks than the MG and LG (23), and that the Sol is
relatively more active when the knee is bent than straight (69). Because of this, the Sol’s
EMG activity was selected for the correlation analysis with the TA. A correlation
coefficient of 1 indicates that the muscles were active at the same time with the same
relative shape, while a value closer to 0 indicates that the EMG signals did not align. It
was hypothesized that a smaller correlation coefficient would be more beneficial during
the FTT because it would indicate that the muscle groups were not opposing each other,
or rather, coactivation was less.
Young adults were hypothesized to have less coactivation than HFO and LFO,
and in older adults, greater coactivation was hypothesized to be associated with a lower
FTC. The data do not fully support this hypothesis. Young had a greater correlation
coefficient than HFO, but there was no difference in the correlation coefficient between
Young and LFO. In the older adults, there was a negative association between the
correlation coefficient and FTC (Figure 6B). It appears that it is more advantageous in
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older adults to have a smaller amount of coactivation, or overlap in TA and Sol activity
during the FTT, consistent with the original hypothesis. However, in Young adults,
greater coactivation was not associated with a lower FTC. It is possible that the Young
adults had compensatory mechanisms to deal with the greater coactivation, such as
producing a greater amount of DF force on each tap. In Young adults, coactivation
appears to play a minimal role in determining FTC, while muscle properties like strength
and speed have a stronger association with FTC.
Notably, there was PF activity between the foot taps in some individuals,
suggesting that some individuals are employing a tapping strategy where the foot is being
actively returned to the ground (Figure 5C). It is possible that those with a lower
correlation coefficient are activating the PF muscles to return the foot to the ground
during the FTT, and those with a higher correlation coefficient are activating their PF
throughout the FTT to stabilize their foot. Interestingly, there was not a relationship
between Act-R and the correlation coefficient in a given trial in older adults, suggesting
that the older adults are employing varying muscle activation patterns to tap as fast as
possible. Overall, the negative association between FTC and the correlation coefficient
supports the hypothesis that greater coactivation limits FTC in older adults.

Contractile Speed
The third hypothesis addressed the relationship between contractile speed of the
DF muscles and FTC in the slower leg in young and older adults during voluntary
ballistic contractions and stimulated twitch contractions. Ballistic contractions with the
target of ~40% MVIC force have been used previously in the literature to quantify the
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maximum voluntary RFD (29). Ballistic contractions of the DF were chosen for this
study because they mimic the contractions necessary for the FTT; both are submaximal
tasks that require rapid activation and deactivation of the DF muscles and modulation of
motor unit recruitment. However, one major difference is that the ballistic contractions
are singular and isometric while the FTT employs dynamic, repeated contractions
through a limited range of motion.
During the voluntary ballistic contractions, the only difference between the
groups was that Young adults had a greater slope of force development than the LFO.
For the stimulated twitch contractions presented on a subset of participants, Young adults
had a faster time to peak force than LFO, and Max RFD was approaching significance
between the groups (Table 5). Time to peak twitch force is dependent on peak force and
is not necessarily indicative of contraction speed. However, Young and LFO had similar
peak twitch forces and LFO had a slower time to peak; therefore, slower time to peak
does indicate slowing of stimulated force development in LFO.
The LFO had slower rates of force development during both their voluntary and
stimulated contractions when compared with the Young adults, indicating slowing of
force development in their DF muscles. The LFO also had a lower FTC than Young.
These relationships were not seen in HFO, suggesting that greater mobility impairments
may be related to slowed DF force development speed and FTC. Kent-Braun et al. did
not see an impairment in central rate of force development during ballistic contractions in
older adults but did see a difference in FTC (29). One possible reason for the difference
between the results of this thesis and Kent-Braun’s study is that they were expressing
RFD as a measure of central function and normalized the voluntary RFD to the
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stimulated RFD, which was not done here. It has been suggested that the FTT can be
used as a measure of central function (29, 59), partially because slowing is seen in
diseases affecting the CNS; however, this thesis did not compare FTC to other measures
of central function, like central RFD.
In the older adults, FTC of the slower leg was correlated with the Max RFD and
Max RFR during the ballistic contractions, but not with the slopes of force development
and relaxation. This suggests that the maximum, instantaneous rate at which the muscle
is able to contract and relax is related to foot tap speed in older adults, but not the speed
of the overall movement. It is possible that the FTT, a dynamic repetitive task, and the
ballistic contractions, a single isometric contraction, were eliciting different responses in
the DF muscles of the older adults. This difference in contraction type could potentially
explain why Max RFD and RFR were related to FTC in older adults but the slope of the
full ballistic contraction was not.
Moderate correlations between FTC and slope of force development and
relaxation were observed in Young adults. The Max RFD was also positively correlated
with FTC in the Young adults. These relationships suggest that contractile speed during
voluntary contractions controls how quickly young adults can perform the FTT.
Differences in muscle contractile speed appear to explain a large amount of the variations
in FTC in the younger adults.
The Young adults produced greater force during maximal DF and PF than LFO.
Peak torque production was correlated with performance on the FTT in the young adults
but not the older adults, indicating that strength impacts FTT performance in young
adults but not older adults. Tomita et al. suggested that one of the advantages of the FTT
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is that participants are not instructed to go through their full range of motion while
tapping and are only instructed to go as fast as possible (76). By removing the restriction
of using the full range of motion, the FTT may be able to reduce the impact strength has
on performance in older adults. This hypothesis is supported by the observation that FTC
and strength were not associated in the older participants. Future studies should examine
the foot’s excursion during the FTT to determine what percent of the range of motion is
employed and whether this impacts FTC. Toe excursion was measured for the FTT,
though the data are not presented.
The M-wave characteristics of the muscle were also determined during the twitch
stimulation, however, it is hard to draw conclusions about the muscle properties from this
data. The M-wave is the EMG response to a single stimulation and generally indicates
the excitability of the muscle (57). However, M-wave amplitude and duration will vary
based on adiposity and distance between electrodes, making it difficult to compare
between individuals (57, 79). Our results suggest that HFO had reduced excitability of
the TA muscle compared to Young, but this could be due, in part, to the smaller twitch
force response in HFO than Young.

Foot Tap Test and Physical Function
The Young and HFO had a faster FTC than LFO, indicating an impairment in foot
tapping speed with age and mobility function. In the older adults, the FTC of the faster
foot was positively associated with SPPB-A score, providing support to hypothesis 4.
Based on the finding that FTC of the slower foot was only related to MVPA, it appears
that FTC of the faster foot is a better predictor of physical function in older adults. It is
possible that the older adults in this study were healthy enough that any reductions in
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function of the slower leg, such as reduced DF during swing phase, could be
compensated for by the faster leg during measures of physical function.
The COV-ITI of the slower foot during the FTT was positively correlated with
SPPB-A and usual walking speed in the older adults, but the COV-ITI of the faster foot
was not. It was hypothesized that greater variability would be indicative of worse
function, but the data does not support this hypothesis. Rather, our results suggested that
a lower COV-ITI could be indicative of a diseased state (18).
Notably, FTC of the faster foot was related to physical function while COV-ITI of
the slower foot was related to physical function in the other adults. This study measured
the FTC on both legs because FTC of the faster, dominate foot is typically reported in the
literature but mobility could be restricted by the more impaired limb (29, 59, 76). This
study was not aimed at comparing the two legs but rather was aimed at understanding
why a slowing of foot tapping speed might occur. Future studies may address the
differences in the faster and slower leg and explore the relationship between function and
asymmetry during the FTT.

Physical Function
The older adults in this study were healthy with minimal limitations to their
physical function. All of the older participants had a usual walking speed above 0.8 m·s1

, which has been proposed as a threshold for identifying individuals with mobility

impairments (72). Another common measure of physical function is the SPPB. The
older adults in this study scored between an 8-12 on the SPPB. A score of 12 on the
SPPB indicates no functional impairment, and a score between 8-10 indicates mild to
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moderate impairment in older adults (15). The SPPB-A was used to separate the older
adults because it reduces the ceiling effect of the SPPB and is a more sensitive measure
of function (70). To the best of our knowledge, there are no set criteria for dividing older
adults based on the SPPB-A. The original paper by Simonsick et al. reported a mode
range of 2.33- 2.66 on the SPPB-A for women and a mode range of 2.66-3 for men (70).
The median value for the older women in our study, 2.47, was within the range reported
by Simonsick, and the median value for the older men in our study, 2.59, was slightly
below the range reported by Simonsick (70). The FTC was sensitive enough to
distinguish between Young and LFO and was related to a composite measure of physical
function in the healthy older cohort. One advantage of the FTT over usual walking speed
and SPPB is that individuals with limited mobility can perform it. However, in a study of
healthy older adults, by itself, the FTT is not indicative of current mobility function.
The participants in this study were moderately active. The HFO and Young group
did not differ in counts, but Young had a greater amount of MVPA than HFO and LFO.
The percent wear time spent in activity was comparable across groups, suggesting that
the older adults remained active but at a lower intensity than the young adults. On
average, the older adults in both groups were meeting PA guidelines of 150 minutes of
MVPA a week (1). The FTC and MVPA were related in the older adults, suggesting
speed of rapid repetitive activation is maintained with physical activity. Although the
older adults in this study were active, their physical function was still reduced compared
to the young adults and reduced function was correlated with foot tapping speed.
According to the SF-36, Young adults scored the lowest in the energy/fatigue
category, contributing to their lower SF-36 score than HFO. When compared to
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normative values for the SF-36, Young scored slightly below their age’s mean for energy,
LFO scored slightly above their age’s mean, and HFO were considerably above the mean
for their age (4). All three groups scored higher than their age’s mean for pain and
physical function, contributing to the idea that this is a healthy group of individuals. The
HFO had a higher overall composite score of the SF-36 than LFO, due in part to the
HFO’s higher scores on energy/fatigue, pain, and physical function. Overall, the quality
of life in HFO was higher than LFO based on the results of the SF-36. Notably, there
was no difference in FES-I score between groups, indicating that the groups had
comparable fears of falling.
The relationship between FTC and physical function in young adults was not
examined in this study, primarily because the Young adults were not expected to have
any functional impairments. The FTT can indicate changes in function, but it is unlikely
that it is related to function in young adults who have a greater number of compensatory
mechanisms than older adults. Likewise, the associations between FTC and potential
moderators of speed were not studied in Young and old combined.

Limitations
A limitation of this study was that the participants were relatively active and
healthy. Participants were, on average, meeting physical activity guidelines of >150 min
of MVPA a week. The Young adults were also more active than LFO and HFO, making
it harder to remove the impact of aging on function. The older adults in this study were
relatively healthy, with all participants having a gait speed greater than 0.8 m·s-1 and an
SPPB ≥8. Having older adults who were frailer have led to different results, such as a
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larger range in function. This study was also a cross-sectional, making it impossible to
test if the FTT can predict future mobility impairments in older adults. This also limits
the exploration of causal relationships between FTC and potential moderators of slow
speed.
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Conclusion
Overall, greater muscle coactivation during the FTT and slowed force
development in the DF muscles negatively affects the speed with which older adults can
perform rapid repetitive foot tapping. Foot tap speed, particularly of the faster foot, and
foot tap variability, particularly of the slower foot, is related to physical function in
healthy to mildly mobility-impaired older adults. In young adults, the largest limiting
factors for rapid repetitive foot tapping is the contractile speed and strength of the DF
muscles.
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CHAPTER 5
SUMMARY

With age, many changes occur within the neuromuscular system which can
negatively affect muscle and mobility function. Among other things, with age there is
slowed activation and deactivation of the dorsiflexor muscle. However, the dorsiflexor
muscles typically are less affected by declines in physical activity associated with aging
compared with other muscle groups, such as the knee extensors and plantar flexors.
Slowed activation and deactivation of the dorsiflexor muscles with age is evident during
rapid tapping tasks, such as the Foot Tap Test (FTT). The FTT is an easy, potentially
useful tool for monitoring changes in dorsiflexion function in older adults. This study
suggests that declines in foot tap speed with age could be caused by greater muscle
coactivation during the FTT and reduced rate of force development of the dorsiflexor
muscles. Declines in the speed of dorsiflexor activation becomes vitally important in
individuals with large mobility impairments; specifically because impaired dorsiflexion
during gait can increase the risk of falling. The FTT is potentially better at tracking
functional changes in a population with mobility impairment and reduced dorsiflexor
function. However, even among the healthy older adults in this study, slower foot tap
speed was related to reduced physical function, which shows promise for predicting
future changes in mobility function (28). Simple tests to measure mobility function, like
the FTT and gait speed, may aid clinicians in tracking the mobility of their patients and
identifying individuals at risk of future mobility impairments. The FTT could also aid in
identifying individuals in need of training interventions to prevent or delay the onset of
mobility impairment.
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Table 1. Participant Characteristics
p value,

Young

HFO

LFO

(n=18)

(n=14)

(n=14)

Age, years

25.0 (3.1)

70.9 (3.1) *

76.0 (5.0)* ǂ

<0.001

BMI, kg/m2

23.1 (2.6)

24.4 (3.8)

25.4 (2.6)

0.101

SPPB-A

3.11 (0.35)

2.78 (0.15) *

2.24 (0.28) *ǂ

<0.001

Usual walk speed, 6m, m·s-1

1.46 (0.28)

1.40 (0.16)

1.11 (0.14)* ǂ

<0.001

400m brisk walk speed, m·s-1

1.92 (0.16)

1.68 (0.15) *

1.53 (0.11) *ǂ

<0.001

FES-I

17.1 (1.8)

18.1 (3.1)

18.9 (2.2)

0.097

656.2 (81.8)

740.3 (48.2) *

667.1 (76.2) ǂ

<0.001

98.9 (2.1)

95.4 (5.7)

89.6 (6.9) *

<0.001

SF-36, Energy/fatigue score

56.9 (13.2)

85.0 (8.8) *

67.9 (13.4) *ǂ

<0.001

SF-36, Pain score

90.6 (16.6)

94.3 (6.5)

82.5 (13.3) ǂ

0.031

295.8 (99.3)

241.9 (127.0)

187.5 (46.8)*

0.011

173.4 (140.6)*

173.2 (84.8)*

0.002

33.7 (8.2)

29.3 (7.5)

0.265

main
effect

Physical Function

SF-36, sum
SF-36, physical function
score

Physical Activity
PA counts/1000·day-1
MVPA, min per week
% of wear time in activity

301.4
(108.8)
29.7 (7.3)

Participant characteristics for Young, Higher Functioning Older (HFO) and Lower
Functioning Older (LFO) adults. Number of participants per group indicated as (n).
Values are mean ±SD; * different than young, ǂ different than HFO. Body Mass Index
(BMI) and Fall Efficacy Scale-International (FES-I) did not differ between groups.
Physical Activity (PA) and minutes of Moderate to Vigorous Physical Activity (MVPA)
were greater in Young than LFO. The Short Form-36 (SF-36) asked about overall health
of the participants and included specific questions for fatigue and pain.
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Table 2: Outcomes of the Foot Tap Test (FTT) of the Faster and Slower Foot
Young

HFO

LFO

(n=18)

(n=14)

(n=14)

main effect

54.4 (7.5)

53.1 (5.7)

45.9 (7.0) *ǂ

0.003

p value,

FTT faster foot
Count
ITI, ms
COV-ITI, %

0.187 (0.022) 0.190 (0.022) 0.223 (0.035) * ǂ

<0.001

20.5 (8.1)

18.7 (7.6)

12.3 (5.9) *

0.009

51.3 (8.0)

48.3 (7.3)

44.9 (6.8)

0.063

0.229 (0.036)

0.060

16.4 (6.6)

0.310

FTT slower foot
Count
ITI, ms
COV-ITI, %

0.200 (0.031) 0.212 (0.033)
19.8 (8.6)

20.7 (7.6)

Data collected on Young, Higher Functioning Older (HFO) and Lower Functioning Older
(LFO) adults during the FTT, including the intertap-interval (ITI) and coefficient of
variability of the ITI (COV-ITI). Foot tap data from the slower foot were collected on
the second visit, simultaneously with EMG and motion capture data. Number of
participants per group indicated as (n). Values are mean ±SD; * different than young ǂ
different than HFO.
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Table 3. Electromyography (EMG) data during the Foot Tap Test from the Slower
Foot
Young

HFO

LFO

(n=18)

(n=13)

(n=14)

TA EMG, %·tap-1

0.444 (0.186)

0.655 (0.173) *

0.700 (0.238) *

0.002

Sol EMG, %·tap-1

0.380 (0.190)

0.856 (0.600) *

0.625 (0.376)

0.008

MG EMG, %·tap-1

0.129 (0.096)

0.302 (0.165) *

0.307 (0.218) *

0.004

LG EMG, %·tap-1

0.255 (0.144)

0.597 (0.350) *

0.449 (0.299)

0.004

1.92 (0.69)

1.45 (1.04)

1.94 (1.10)

0.307

0.568 (0.209)

0.321 (0.129) *

0.437 (0.159)

0.001

Activation-ratio
Correlation

p value,
main
effect

coefficient

Electromyography (EMG) collected during the Foot Tap Test for the tibialis anterior
(TA), soleus (Sol), medial gastrocnemius (MG) and lateral gastrocnemius (LG) muscles
in Young, Higher Functioning Older (HFO) and Lower Functioning Older (LFO) adults.
The EMG data is normalized to EMG activity during a maximal voluntary contraction
and to the number of foot taps. Number of participants per group indicated as (n).
Values are means ±SD; * different than young ǂ different than HFO. Tukey’s PostHoc
run to test for significance.
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Table 4. Voluntary Contractile Speed of the Slower Foot during Ballistic
Contractions

Force, % MVIC
Slope of force

p value,

Young

HFO

LFO

(n=18)

(n=13)

(n=14)

44.3 (6.0)

46.9 (6.26)

44.8 (5.8)

0.461

0.137 (0.039)

0.117 (0.035)

0.098 (0.031) *

0.013

0.115 (0.040)

0.112 (0.039)

0.093 (0.043)

0.259

1.080 (0.190)

1.037 (0.174)

0.998 (0.139)

0.412

-1.004 (0.170)

-1.012 (0.188)

-0.961 (0.218)

0.753

main
effect

development, Nm·ms-1
Slope of force
relaxation, Nm·ms-1
Max RFD,
%peak force·s-1
Max RFR,
%peak force·s-1

Dorsiflexor contractile speed collected during voluntary ballistic contractions to ~45% of
Maximal Voluntary Isometric Contractile (MVIC) force in Young, Higher Functioning
Older (HFO) and Lower Functioning Older (LFO) adults. The dorsiflexor muscles were
tested for contractile properties, including Slope of force development and relaxation, and
Maximal Rate of Force Development (Max RFD) and Relaxation (Max RFR). Number
of participants per group indicated as (n). Values are means ±SD; * different than young
ǂ
different than HFO. Tukey’s PostHoc run to test for significance.
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Table 5. Dorsiflexion Contractile Characteristics of Slower Leg during Stimulated
Twitch Contractions
Young

HFO

LFO

(n=13)

(n=12)

(n=6)

9.20 (1.43)

7.19 (2.21) *

6.90 (1.18) *

0.009

M-wave duration, ms

38.5 (3.2)

34.4 (5.2) *

38.4 (2.1) ǂ

0.046

M-wave negative peak, mV

5.31 (0.94)

3.97 (1.28) *

4.13 (0.69)

0.009

Peak Twitch force, Nm

2.76 (0.77)

1.95 (0.73) *

2.61 (0.39)

0.021

Max RFD, %peak·s-1

2.26 (0.31)

2.33 (0.47)

1.88 (0.25)

0.056

Max RFR, %peak·s-1

-1.11 (0.25)

-1.18 (0.53)

-0.85 (0.11)

0.225

Time to peak force, ms

93.5 (11.3)

99.7 (16.2)

111.8 (15.1) *

0.045

T1/2, ms

71.9 (16.8)

84.0 (31.1)

95.2 (7.8)

0.115

M-wave amp, peak to peak,

p value,
main
effect

mV

Twitch and M-wave data from a subset of participants in the Young, Higher Functioning
Older (HFO) and Lower Functioning Older (LFO) groups. Twitch contractile
characteristics include maximal rate of force development (Max RFD) and relaxation
(Max RFR), time to peak force, and time until half relaxation (T1/2). Number of
participants per group indicated as (n). Values are means ±SD; * different than young ǂ
different than HFO. Tukey’s PostHoc run to test for significance.
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Table 6. Regression Analyses for Potential Moderators of Foot Tap Count (FTC) of
the Slower Leg in Young and Older Adults

FTC in older adults

FTC in young adults

r2

p value

r2

p value

0.001

0.855

0.024

0.541

Act-R

0.024

0.442

Correlation coefficient

0.274

0.005

0.087

0.236

% MVIC force

0.090

0.128

0.024

0.540

Slope of force development

0.117

0.081

0.523

0.001

Slope of force relaxation

0.135

0.059

0.394

0.005

Max RFD

0.345

0.001

0.245

0.037

Max RFR

0.162

0.038

0.032

0.476

0.173

0.387

0.476

0.002

Foot Tap Variability
COV-ITI slower foot
Muscle coactivation

Ballistic contractions

MVIC force, N·m-1

Foot Tap Count and COV-ITI for the same trial was compared for and slower foot in
older adults. Coactivation was determine based on the correlation coefficient and relative
muscle activation was determined by the activation ratio (Act-R). Foot Tap Count was
also compared with force of ballistic contractions, which were ~ 45% of peak Maximal
Voluntary Isometric Contraction (MVIC) force. Foot tap count was compared with
dorsiflexor contractile properties, including Slope of force development and relaxation,
and maximal rate of force development (Max RFD) and relaxation (Max RFR). Bolded
lines indicate regressions with p<0.05.
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Table 7. Regression Analyses for Foot Tap Count (FTC) and Measures of Physical
Function in Older Adults

FTC of faster foot vs

FTC of slower foot vs

function in older adults

function in older adults

r2

p value

r2

p value

SPPB-A

0.329

0.001

0.111

0.084

Usual walking speed

0.104

0.094

0.009

0.633

400m walking speed

0.072

0.176

0.096

0.108

MVPA

0.158

0.040

0.143

0.065

PA counts

0.211

0.014

0.117

0.075

age

0.277

0.004

0.023

0.441

Foot Tap Count from the faster and slower feet (visit 2) in older adults compared with
measures of physical function. Functional measures included the advance Short Physical
Performance Battery (SPPB-A), usual walking speed, 400m walking speed, minutes of
Moderate to Vigorous Physical Activity (MVPA) a week, and age. Bolded lines indicate
regressions with p<0.05.
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Table 8: Regression Analyses for Variability of the Intertap Interval (COV-ITI)
during the Foot Tap Test and Measures of Physical Function in Older Adults

COV-ITI of faster foot vs

COV-ITI of slower foot vs

function in older adults

function in older adults

r2

p value

r2

p value

SPPB-A

0.077

0.153

0.181

0.024

Usual walking speed

0.110

0.084

0.202

0.017

400m walking speed

0.001

0.894

0.029

0.212

MVPA

0.166

0.035

0.001

0.861

PA counts

0.036

0.334

0.011

0.590

age

0.002

0.815

0.051

0.248

Variability of tapping (COV-ITI) during the Foot Tap Test from the faster and slower feet
(visit 2) in older adults compared with measures of physical function. Functional
measures included the advance Short Physical Performance Battery (SPPB-A), usual
walking speed, 400m walking speed, minutes of Moderate to Vigorous Physical Activity
(MVPA) a week, and age. Bolded lines indicate regressions with p<0.05.
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Figure 1. Summary of Primary Hypotheses and Results

A

B

C

A) Summary schematic of the hypotheses for older adults. Solid arrows indicate a
hypothesized moderator of Foot Tap Count (FTC) and the dotted arrow indicates a
predictive relationship between FTC and function. The numbers in each figure indicate
the corresponding hypothesis. B) Summary schematic of the results in older adults. C)
Summary schematic of the results in young adults. Thicker lines in panels B and C
indicate supported hypotheses. X indicates unsupported hypothesis.
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Figure 2. Experimental Arrangement for the Foot Tap Test and Sample Force
Output

A)

C)

B)

A) Placement of foot for the FTT. Participants were seated so the ball of the foot was on
the force platform and the heel was off the force platform; retroreflective markers were
place on specific anatomical locations to track foot movement; B) Retroreflective
markers viewed in Qualysis; the arrow represents the net ground reaction force applied to
the force platform; C) Sample force tracing from the FTT; local maxima are identified
with a circle.
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Figure 3. Examples of Force Platform Fata from the Foot Tap Test

A) COV-ITI = 20.9%

B) COV-ITI = 19.3%

C) COV-ITI = 13.3%

An example of foot tap data recorded on the force platform from A) Young, B) Higher
functioning older, and C) Lower functioning older adults. A larger coefficient of
variation of the intertap-interval (COV-ITI) indicates greater variability in foot tap
timing. Examples were selected to be close to each group’s average COV-ITI.
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Figure 4: Example of Voluntary Ballistic Contraction and Calculation of Slope and
Maximum Rate of Force Development (Max RFD)

An example voluntary ballistic dorsiflexion contraction is shown in gray. The Max RFD,
shown here by a black dot, is the greatest instantaneous change in force. The slope of
force development, shown here as a dotted line, was calculated as the change in force
from baseline divided by the change in time from the beginning of the force rise above
baseline to peak force.
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Figure 5: Examples of Normalized Electromyography (EMG) Signal during the
Foot Tap Test (FTT)
A) Normalized EMG for 10s of FTT

B) Normalized EMG for 1s of FTT from Young

C) Normalized EMG for 1s of FTT from HFO

A) Example of normalized EMG for each muscle during 10s of rapid foot tapping. B)
Example of normalized EMG for 1s of foot tapping in a Young adult; activation ratio
(Act-R) = 2.21, correlation coefficient = 0.59. C) Example of normalized EMG for 1s of
foot tapping in a HFO adult; Act-R = 1.24, correlation coefficient = 0.30. For each
muscle, the EMG data during the FTT were normalized to EMG data during a maximal
voluntary isometric contraction.
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Figure 6. Activation, Coactivation and Foot Tap Count in Older Adults
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6.0

EMG Activation Ratio

0

0.2
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0.6

0.8
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Electromyography (EMG) data were collected during the Foot Tap Test for the slower
foot at Visit 2. Data are presented from the fastest trial on Visit 2. A) Foot Tap Count
was not related to the Coact-R. B) Foot Tap Count was negatively related with the
correlation coefficient (TA:Sol) in older adults. Higher functioning older adults are
indicated by red circles and lower functioning older adults indicated by blue triangles.
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1

Figure 7. Foot Tap Counts and Voluntary Slope of Force Development and
Relaxation of the Dorsiflexor Muscles during Ballistic Contractions in Young and
Older Adults

B) Older
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Foot Tap Count vs slope of force development during ballistic contractions of slower foot
in A) young, and B) older adults. Foot Tap Count vs slope of force relaxation during
ballistic contractions of slower foot in C) young, and D) older adults. Higher functioning
older adults indicated by red circles and lower functioning older adults indicated by blue
triangles.
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Figure 8. Foot Tap Counts and Voluntary Maximum Rate of Force Development
and Relaxation (Max RFD and RFR) of the Dorsiflexor Muscles during Ballistic
Contractions in Young and Older Adults
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Foot Tap Count vs maximum rate of force development (Max RFD) during ballistic
contractions of slower foot in A) young, and B) older adults. Foot Tap Count vs
maximum rate of force relaxation (Max RFR) during ballistic contractions of slower foot
in C) young, and D) older adults. Higher functioning older adults indicated by red circles
and lower functioning older adults indicated by blue triangles.
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Figure 9: Correlations between Foot Tap Count (FTC) of the Faster Foot and
Function in Older Adults
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Associations in older adults between FTC and A) advanced Short Physical Performance
Battery (SPPB-A), B) 400m brisk walk speed, C) minutes of Moderate-to-Vigorous
Physical Activity a week (MVPA), D) age. Higher functioning older adults are indicated
by red circles and lower functioning older adults indicated by blue triangles.
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Table 9. Habituation Session Schedule
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Table 10. Testing Session Schedule
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Table 11. Summary of statistical analyses and hypothesis testing

91

Table 9: Habituation Session Schedule
Activity

Time

Data collected

(min)
Informed consent, Medical
15
history form, FES-I, Par-Q, SF-36
Resting BP, height and body mass 5

FES-I score

PA monitor explanation

5

PA log, PA activity for 7 days

Physical Function measures

15

Familiarization: MVC, foot tap

20

SPPB and SPPB-A score, force
platform data from balance tests and
chair rise
FTS for each leg; testing leg

BP, height, body mass, BMI

determined
Stimulation

20

Total time

~80

Torque (voluntary and
stimulated),CAR, RFD, T1/2
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Table 10: Testing Session Schedule

Activity

Time (min)

Data collected

Warm up cycling and stretching
EMG electrode placement and
signal check

7
10

None
None

MVCs: plantar and dorsiflexion

20

Motion capture markers placement
and standing calibration, FTTs
explained

7

EMG for TA, GM, GL, SO; torque
for MVCs
Standing calibration

10 s foot tap test x3

10

# taps from the counter, GRF,
motion capture, EMG

30, 60 and 100% trials

10

# taps from the counter, GRF,
motion capture, EMG

100m walk- preferred gait speed

5

400 m walk- brisk walk

10

motion capture, EMG, speed (3
times each)
motion capture, EMG, speed (10
times each)

Total time

~80
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Table 11: Summary of statistical analyses and hypothesis testing

Hypothesis

Primary Variables

Groups

Statistic

1.1

FTS

Young, older, older
impaired

ANOVA

1.2

CoActM (FTT)

Young, older, older
impaired

ANOVA

1.3

CoActT (FTT)

Young, older, older
impaired

ANOVA

1.4

CoActM (FTT)
FTS

All older

Linear regression

2.1

CoActM (400m walk)

Young, older, older
impaired

ANOVA

2.2

CoActM (400m walk)
Gait speed

All older

Linear correlation
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Figure 10. Set up of Foot Tap Tests
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Figure 10: Set up of Foot Tap Tests
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Medical History Form
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Physical Activity Readiness Questionnaire
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Falls Efficacy Scale-International
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Short Form-36
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Short Physical Performance Battery (SPPB) scoring chart

106

Advanced Short Physical Performance Battery (SPPB-A) scoring chart
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Medical History Form
Please fill out and sign in ink. This record is confidential.
Medical History
Do you take any prescribed or over-the-counter medications? Please include vitamins,
herbs, or other dietary supplements. If yes please list the dose, frequency and the duration
of use.
________________________________________________________________________
________________________________________________________________________
Have you ever been told by a physician that you should not exercise?
Yes ____

No ____

If yes, please explain:

________________________________________________________________________
________________________________________________________________________

Do you have or have you EVER had any of the following problems? Check if YES and
provide details below.
____ Heart disease/rheumatic fever
____ Thyroid disorder
____Asthma
____ High blood pressure
____ Claustrophobia
____Allergies
____ Elevated Cholesterol
____ Anemia
____Stroke
____ Epilepsy or seizure disorder
____Diabetes
____ Blurred or double vision
____ Orthopedic or joint problems (e.g., arthritis)
____ Shortness of breath or difficulty in breathing
____ Phlebitis, blood-clots, varicose veins, peripheral vascular disease
Lifestyle
Do you smoke cigarettes?
Do you drink alcohol?
Do you get regular exercise?
Have you had surgery?

____Dizziness

Yes ____
No ____
Yes ____
No ____
Yes ____
No ____
If yes, number of times per week ________
Yes ____
No ____
If yes, when was this? _________________

Is there any other information or concerns you have that you feel we should know about
before you participate in the study? If yes please explain.
________________________________________________________________________
________________________________________________________________________
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Physical Activity Readiness Questionnaire
1. Has a doctor ever said you have a heart condition and recommended only medically
supervised activity?
YES_______

NO_______

2. Do you have chest pain brought on by physical activity?
YES_______

NO_______

3. Have you developed chest pain in the last month?
YES_______

NO_______

4. Do you tend to lose consciousness or fall over as a result of dizziness?
YES_______

NO_______

5. Do you have a bone or joint that could be aggravated by the proposed physical activity?
YES_______

NO_______

6. Has a doctor ever recommended medication for your blood pressure or a heart
condition?
YES_______

NO_______

7. Are you aware through your own experience, or a doctor’s advice, of any other physical
reason against your exercising without medical supervision?
YES_______

NO_______

Note: If you have a temporary illness, such as a common cold, or are not feeling well at this
time – POSTPONE.
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Falls Efficacy Scale-International

100

Short Form-36

Medical Outcomes Study: 36-Item
Short Form Survey Instrument
RAND 36-Item Health Survey 1.0 Questionnaire Items

1. In general, would you say your health is:
Excellent
Very good
Good
Fair
Poor

1
2
3
4
5

2. Compared to one year ago, how would you rate your health in general
now?
Much better now than one year ago

1

Somewhat better now than one year ago

2

About the same

3

Somewhat worse now than one year ago

4

Much worse now than one year ago

5

The following items are about activities you might do during a typical day.
Does your health now limit you in these activities? If so, how much?
(Circle One Number on Each Line)
Yes, Limited
a Lot

Yes,
Limited a
Little

No, Not
limited at
All

3. Vigorous activities, such as running, lifting heavy
objects, participating in strenuous sports

[1]

[2]

[3]

4. Moderate activities, such as moving a table,
pushing a vacuum cleaner, bowling, or playing golf

[1]

[2]

[3]

5. Lifting or carrying groceries

[1]

[2]

[3]

6. Climbing several flights of stairs

[1]

[2]

[3]

7. Climbing one flight of stairs

[1]

[2]

[3]

8. Bending, kneeling, or stooping

[1]

[2]

[3]

9. Walking more than a mile

[1]

[2]

[3]
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Yes, Limited
a Lot

Yes,
Limited a
Little

No, Not
limited at
All

10. Walking several blocks

[1]

[2]

[3]

11. Walking one block

[1]

[2]

[3]

12. Bathing or dressing yourself

[1]

[2]

[3]

During the past 4 weeks, have you had any of the following problems with
your work or other regular daily activities as a result of your physical
health?
(Circle One Number on Each Line)
Yes

No

13. Cut down the amount of time you spent on work or other activities

1

2

14. Accomplished less than you would like

1

2

15. Were limited in the kind of work or other activities

1

2

16. Had difficulty performing the work or other activities (for example, it took
extra effort)

1

2

During the past 4 weeks, have you had any of the following problems with
your work or other regular daily activities as a result of any emotional
problems (such as feeling depressed or anxious)?
(Circle One Number on Each Line)
Yes
17. Cut down the amount of time you spent on work or other activities

No
2

18. Accomplished less than you would like

1

2

19. Didn't do work or other activities as carefully as usual

1

2

20. During the past 4 weeks, to what extent has your physical health or
emotional problems interfered with your normal social activities with
family, friends, neighbors, or groups? (Circle One Number)
Not at all 1
Slightly
2
Moderately 3
Quite a bit 4
Extremely 5
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21. How much bodily pain have you had during the past 4 weeks? (Circle
One Number)
None
1
Very mild 2
Mild
3
Moderate 4
Severe
5
Very severe 6
22. During the past 4 weeks, how much did pain interfere with your normal
work (including both work outside the home and housework)? (Circle One
Number)
Not at all 1
A little bit 2
Moderately 3
Quite a bit 4
Extremely 5
These questions are about how you feel and how things have been with
you during the past 4 weeks. For each question, please give the one answer
that comes closest to the way you have been feeling.
How much of the time during the past 4 weeks . . .
(Circle One Number on Each Line)
All of the Most of A Good Bit
Time
the Time of the Time

Some of
the Time

A Little of
the Time

None of
the Time

23. Did you feel full of pep?

1

2

3

4

5

6

24. Have you been a very
nervous person?

1

2

3

4

5

6

25. Have you felt so down in 1
the dumps that nothing could
cheer you up?

2

3

4

5

6

26. Have you felt calm and
peaceful?

1

2

3

4

5

6

27. Did you have a lot of
energy?

1

2

3

4

5

6

28. Have you felt
downhearted and blue?

1

2

3

4

5

6
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29. Did you feel worn out?

1

2

3

4

5

6

All of the Most of A Good Bit
Time
the Time of the Time

Some of
the Time

A Little of
the Time

None of
the Time

30. Have you been a happy
person?

1

2

3

4

5

6

31. Did you feel tired?

1

2

3

4

5

6

32. During the past 4 weeks, how much of the time has your physical
health or emotional problems interfered with your social activities (like
visiting with friends, relatives, etc.)? (Circle One Number)
All of the time 1
Most of the time 2
Some of the time 3
A little of the time 4
None of the time 5
How TRUE or FALSE is each of the following statements for you.
(Circle One Number on Each Line)
Definitely
True

Mostly
True

Don't
Know

Mostly
False

Definitely
False

33. I seem to get sick a little easier
than other people

1

2

3

4

5

34. I am as healthy as anybody I
know

1

2

3

4

5

35. I expect my health to get worse 1

2

3

4

5

36. My health is excellent

2

3

4

5

1
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Short Physical Performance Battery (SPPB) scoring chart
4
< 4.82

3
4.82-6.20

2
6.21-8.70

1
>8.70

<11.1

11.2-13.6

13.7-16.6

>16.7

Not needed

Not needed

Not needed

10

Semi-tandem
(s)

10

10

10

Full Tandem
(s)

10

3-9

0-9; tried but
unable; not
attempted
Not needed

Walk Time (s)
Chair Rise
Time (s)
Balance Tests:
Side-by-side
(s)

0
Unable to
complete
Unable to
complete
0-9; tried but
unable; not
attempted
<10; Tried
but unable;
not attempted
Not needed

0-2; tried but
unable; not
attempted
*For the balance test, if an individual is able to hold the semi-tandem pose for 10s they

will not be tested in the side-by-side position, which is considered easier. If an individual
is unable to hold the semi-tandem pose for 10s, they will not be tested in the full tandem
position because it is considered more difficult.
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Advanced Short Physical Performance Battery (SPPB-A) scoring chart
6m walk (casual speed; s):

1) __________

2)__________

6m balance walk (casual speed, s):
________

1) __________

# times stepped outside

2) __________

# times stepped outside

________
Timed 5x Chair rise (s): ________ (split time)
______________

Force file name

Timed 10x Chair rise (s): ________
Balance
Time (s)
Force File

Side-by-Side

Semi-Tandem

Tandem

One-leg

Leg selected R L

Scoring for Advanced Short Physical Performance Battery
1. Total Advanced Balance Test Score ( 0 – 1)
(Semi-tandem+ tandem + one leg time)/90s)

2. Normalized Gait Speed
(4m/time)/(2 m/s)

3. Normalized Balance Gait Speed
(4m/time)/(2 m/s)

3. Repeated chair stand ratio score
(10 stands/ time to complete)

4. Total Advanced SPPB Score
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.

points

.

points

.

points

.

points

.

points

APPENDIX D
ADDITIONAL MEASURES COLLECTED

Data were collected for the following measures but were not analyzed for this thesis
•

•
•
•

•

•

Force platform data during 30s balance tests
o Feet side-by-side, semi-tandem, tandem, single leg stance
o No motion capture or EMG data
Learning effect or repeatability of FTT from visit 1 to visit 2
Asymettry of the two feet during the FTT on visit 1
Speed, EMG, and motion capture of slower leg during preferred walking speed
trials and during 400m walk
o Analysis has been completed on the 400m walk but was not completed
with enough time to add it to this paper
Foot tap data for 30, 60, 100% of max FTT speed. Individuals were instructed to
match the metronome speed while performing the task
o Intertap-interval and coefficient of variation of the intertap-interval
Toe excursion during the Foot Tap Test
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